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ABSTRACT
The uptake, metabolism and toxicological implications of some inhaled halogenoalkanes have 
been investigated in the rat. In these experiments chlorinated alkanes of the series CX4 , 
CHX 3 , CH 2 X2  and CH 3 CX3 , where X =  Cl or F have been used. The serial replacement 
of a chlorine by fluorine provided a means of comparison of uptake characteristics with 
metabolic activities that could be related to this substitution. A closed recirculating 
atmospheric exposure system was used and the depletion rate of chemicals from the 
atmosphere was monitored as uptake and metabolism proceeded. After the exposure, the 
concentration of total glutathione and glutathione disulphide (GSSG) in liver and lung, and 
selected serum enzyme activities were determined. The results were correlated with the 
physico-chemical properties of the compounds - molar polarizability (amol), activation 
energy (AE), and partition coefficient (log P).
The rate of uptake of chemicals decreased with increased fluorine content and correlated 
directly with calculated log P and amol. None of the compounds studied depleted total 
glutathione in lung or increased GSSG in liver or lungs. Total glutathione depletion was 
observed in liver with the compounds CCI4 , CHCI3 , CHF 3 , CH2 CI2 , CH 2 CIF, and all the 
CH 3 CX3  series. There were neither changes in serum enzyme activities nor observable 
damage in liver or lung in all rats exposed to all compounds except for CHCI2 F. For this 
compound, raised sorbitol dehydrogenase activity was recorded in sera of rats either 2  or 24h 
after exposure and was consistent with histologically observable changes in liver.
In in vitro experiments with hepatic microsomal fractions from rats pretreated with 
phenobarbitone, all compounds showed type I binding spectra. The binding affinity for 
hepatic P450 (KJ was greatest with compounds with high chlorine content and varied 
inversely with calculated log P except for the CHX3  series. For this series, the highest 
value was recorded for CHF3 . A positive linear relationship was established between log 
values and log P for all compounds.
Upon incubation of the compounds under aerobic conditions with hepatic microsomes from 
rats pretreated with phenobarbitone, a NADPH generating system and reduced GSH, only 
CHCI3 , CCI4  and CCI3 F depleted GSH.
Spectral peaks were recorded with either sodium dithionite- or NADPH-reduced microsomal 
fractions and the compounds under investigation at either 444-450nm or 415-418nm 
respectively.
Under anaerobic conditions, CH 3 CCI3 , CH 3 CCI2 F, CH 2 CI2 , CH 2 FCI, CHCI3 , CHCI2 F, CHF3 , 
CCI4 , CCI3 F showed marked GSH depletion when incubated with GSH, NADPH generating 
system and hepatic microsomes from rats pretreated with phenobarbitone which suggests a 
reductive metabolic pathway for these compounds and formation of reactive intermediates.
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GSH
Reduced GSH 
Total GSH 
GSSG 
Hb
NADPH
NADP
NADH
MFO
SDH
LDH
GDH
glutathione 
reduced glutathione 
total glutathione 
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haemoglobin
n ic o t in e  a d e n in e  d in u c le o t id e
phosphate (reduced)
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mixed function oxidase system 
sorbitol dehydrogenase 
lactate dehydrogenase 
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CHAPTER 1
GENERAL INTRODUCTION
1.0 FOREWORD
Although there is considerable literature on the metabolism of chlorinated hydrocarbons and 
their effect on cytochrome P450 and drug metabolism, little has been reported on their 
fluorinated analogues. This presumably, is due to the low acute and chronic toxicity 
demonstrated for the hydrochlorofluoroalkanes. The increasing use of 
hydrochlorofluoroalkanes in applications that result in the exposure of the general population 
would, therefore, exacerbate any risks that may exist.
The majority of chlorofluoroalkanes (CFCs) and hydrochlorofluoroalkanes that are in use or 
are being considered for potential use, are small relatively simple molecules. 
Chlorofluorocarbons are known to deplete stratospheric ozone (Molina and Rowland, 1974). 
As a result, hydrochlorocarbons are being developed as substitutes for CFCs (Zurer, 1989; 
Reisch, 1989).
1.1 PROPERTIES
The fluorinated alkanes are all volatile compounds compared with their chlorinated 
analogues. Table 1.1 shows the boiling points of some halogenoalkanes. The table shows 
that substitution of a hydrogen atom by a chlorine is accompanied by an increase in the 
boiling point. In contrast, the substitution of a fluorine for a chlorine leads to a decrease in 
the boiling point and consequently an increased volatility of the compound. The
Table 1.1 THE BOILING POINTS OF SOME HALOGENATED ALKANES
Chemical Boiling point (°C)
CH4 -161.0
CF, -129.0
CCIF3 -81.1
CCFF, -29.9
CCI3 F 23.8
CCI4 76.8
CHCI3 61.6
CHCLF 9.0
CHCIF; -39.8
CHF3 -82.2
CHXU 40.1
CH3 CIF -9.1
CH3 F3 -51.6
incorporation of fluorine in industrial compounds, including therapeutic agents, is based on 
a number of factors as follows:
- fluorine, the second smallest substituent, closely mimics hydrogen with respect to steric 
requirements at enzyme receptor sites
- fluorine with its very high electronegativity frequently alters electronic effects and, as a 
result, chemical reactivity
- the strength of the carbon-fluorine (C-F) bond exceeds that of the carbon-hydrogen (C-H) 
bond to the extent that a single C-F bond requires approximately 28 kJ mol'^ more to break 
than does the C-H bond. This difference more or less accounts for observed increases in 
thermal and oxidative stability of organofluorine compounds.
The replacement of hydrogen by fluorine usually increases lipid solubility (CFCI3  and CCI2 F 2  
are more lipid soluble than CHCI3  and CHCI2 F) and this, in turn, enhances the rates of 
absorption and transport of drugs in vivo. The trifluoromethyl group is among the most 
lipophilic of all substituents.
1.2 PHYSICO-CHEMICAL PROPERTIES
1.2.1 PARTITION COEFFICIENT
The solubility of a gas or vapour in a liquid is normally expressed by the partition coefficient 
which is defined as the ratio of the concentration of the gas or vapour in the liquid to that 
in the gas phase at equilibrium. Partition coefficients of biologically active compounds 
between blood and air, oil and air and oil and water is used widely for the study of structure- 
activity relationships. Miller et al. (1972) reported a linear relationship between ED 5 0  and 
olive oil/air partition coefficients of 20 narcotics such as ether and chloroform. Morgan et 
al. (1972) argued, however, that a close correlation between the partition coefficient and a 
biological response did not necessarily mean that the substance with the largest coefficient 
had the highest toxic potency. Some specific toxicities are known to be caused not by the 
parent substance itself but by its active metabolite as in the examples of hepatotoxicity of 
CCI4  (Recknagel, 1967) and haematopoietic disorders in chronic benzene poisoning (Gillette 
et al., 1974). The partition coefficient of highly lipophilic compounds is often expressed in 
logarithmic form, log P.
1.2.2 MOLECULAR POLARIZABILITY (amol)
The molecular polarizability gives an indication of the ability of a molecule to form a dipole, 
i.e. to polarize, under the influence of an external electric field, which may occur in certain 
environments such as in the vicinity of dipolar and charged species (Atkins, 1974; Lewis, 
1981). This quantity is also calculable by molecular orbital techniques where it is obtained
from a summation of contributions from atomic polarizabilities. As is the case with dipole 
moments, molar polarizabilities are experimentally measurable quantities and may be 
calculated from refractive indices.
Polarizability makes an important contribution to the partitioning between two phases and, 
therefore, it is a major component of the hydrophobic parameter, log P. Hansch and Coats, 
(1970) and Leo et al., (1969) have used polarizability to relate with the hydrophobic 
parameter log P. Handa et a!., (1983) have demonstrated the dependence of anaesthetic 
activity on molecular polarizability obtained from experimental values. It is well known that 
anaesthetics derive their biological activity as a result of their partition coefficients, and this 
finding has given further weight to the parallelism between log P and polarizability (Lewis, 
1989).
1.2.3 ACTIVATION ENERGY, AE
This electronic parameter is obtained from the difference between energies of the highest 
occupied and lowest empty molecular orbitals and its units are electron volts (eV).
AE =  E(LEMO) - E(HOMO)
where E(LEMO) and E(HOMO) are the energies of the highest occupied and lowest empty 
molecular orbitals respectively.
It could be regarded as being comparable with the difference between electron affinity and 
ionization potential and as such, represents the energy required to promote an electron from
its highest occupied energy level to the lowest empty level. The AE parameter, as calculated 
from the molecular orbital descriptions of electronic structure is often equated with 
activation energy, i.e. the energy required to activate a molecule from its ground state to the 
first excited state. In intermolecular interactions, AE makes a contribution to the energy for 
charge transfer processes to occur. (Lewis, 1981).
1.3 USES
Chlorofluoroalkanes are used for both domestic and industrial refrigeration. Due to its 
optimum temperature - pressure relationship, uninflammability and low inhalation toxicity, 
dichlorodifluoromethane was prepared specifically for use as a refrigerant to replace the 
inflammable ethylene and the corrosive and toxic ammonia and sulphur dioxide (Midgley and 
Henne, 1930).
An important use of chlorofluoroalkanes is in the field of aerosol propellants. The extensive 
use of chlorofluoroalkanes as aerosol propellants is due to their lack of inflammability, the 
apparent low toxicity and the fact that these compounds are volatile liquids or easily 
liquefiable gases. The aerosol packaging technique has been applied to a wide variety of 
products including insecticides, room deodorants, hair lacquer and perfumes, paints and 
medicinal products. The medicinal products cover a wide range of uses such as application 
of dermatological products or local anaesthetics. A mixture of trichlorofluoromethane and 
dichlordifluoromethane was used in aerosol form as a pain-relieving spray to give some relief 
by cooling and reducing the sensory output of pain nerve endings.
Chlorofluoroalkanes were used as propelled plastic foaming agents and may be used on 
wounds and burns as an antiseptic. Drugs designed for inhalation may be packed in aerosol 
form.
Due to their ozone depletion potentials, chlorofluoroalkanes have been substituted by 
hydrochlorofluorocarbon s. Chlorodifluoromethane which is mainly used as refrigerant, is 
unlikely to feature in the ozone depletion debate which has implicated some of the 
chlorofluorocarbons (Derwent and Curtis, 1981; Rowland and Molina, 1975) because of its 
low potential for reaching the stratosphere intact and its comparatively small production.
The less volatile halogenoalkanes may be used in industry as solvents. Other uses include 
as chemical intermediates, and in the manufacture of photographic films, fire extinguishers, 
pressurized spray products and Christmas tree bubble lights.
Aliphatic chlorinated hydrocarbons of relatively low molecular weight, have found a number 
of applications in the food industry. They have been used as extraction solvents e.g. 
dichloromethane which is used for coffee decaffeination. Also the chlorinated hydrocarbons 
are used in the removal of undesirable constituents from spice oleo-resins and beer hops, in 
the preparation of foods for freeze drying and for the dehydration and peeling o f fruits and 
vegetables (Valle-Riestra, 1974; Beckel et al., 1948). In addition, they have served a useful 
role as mould inhibitors and fumigants in the preservation and storage of certain crops 
(Vandemark and Sharvelle, 1952; Bouhelier and Foury, 1938).
1.4 HUMAN EXPOSURE
Exposure of humans to the halogenoalkanes may be accidental, which is most likely to be 
due to leaking refrigerant from either domestic or industrial appliances. Their presence in 
foods, either as a consequence of their retention after being used in these roles or as a result 
o f their migration from food packaging has been demonstrated (Anon, 1961; Page and 
Charbonneau, 1977 a, b; Roberts, 1968; Malone, 1969). Deliberate exposure has occurred 
as in abuse (Bass, 1970) arising from their easy availability as propellants, and fatalities came 
to be attributed to their inhalation in so-called "sudden sniffing death". Incidental exposure 
occurs either through the use of aerosol spray in domestic applications e.g. room air 
freshener, insecticides or in medicinal use.
1.5 UPTAKE STUDIES IN EXPERIMENTAL ANIMALS
Gas uptake studies are potentially useful for investigation of the metabolism of inhaled 
toxicants in vivo. Basically these studies are conducted simply by exposing animals to a 
recirculated atmosphere containing initially a specific concentration of toxicant and 
monitoring the rate of depletion of toxicant from the atmosphere as respiration proceeds. 
Closed atmosphere gas uptake studies have been used to assess the metabolism of inhaled 
gases and vapours in vivo (Hefner et al., 1975; Filser and Bolt, 1979; Andersen et al., 1979; 
Gargas and Andersen, 1982).
The primary advantage of these inhalation techniques is that they yield kinetic constants of 
metabolism as it occurs in vivo. The metabolism of several chemicals has been investigated
by gas uptake techniques, for example, Freons 113 and 114, methyl chloride, halothane and 
others (Andersen et al., 1980); halogenated ethylenes (Filser and Bolt, 1979); benzene and 
toluene (Hildebrand and Andersen, 1981). Rate curves of uptake have been obtained for a 
variety of chemicals including methyl chloride (McKenna et ah, 1979), vinylidene chloride 
(Andersen et ah, 1979), vinyl bromide (Gargas et ah, 1980) and halothane (Gargas and 
Andersen, 1979). Gargas et ah, (1986) have studied the metabolism of five dihalomethanes 
in the rat and differentiated the kinetic constants for their two independent metabolic 
pathways.
Andersen et ah, (1980) reported that no appreciable uptake was observed with those high 
vapour pressure materials which also have very low solubility in water e.g. vinylidene 
fluoride. Freon 113 and 114. According to these authors, large concentrations of these 
compounds were required to produce modest blood levels due to their very small blood:air 
partition coefficients. The partition coefficient of chemicals is an essential parameter in 
studying their inhalation toxicokinetics in animals. With dihalomethanes, Gargas et ah, 
(1986) showed that solubility increased with their molecular weight and decreased with 
electronegativity of the halogen pairs.
Litchfield and Longstaff, (1984) evaluated the toxicity of chlorodifluoromethane, and 
reported that the inhaled compound appeared to be almost unchanged when given to rats. 
Only about 0.1% of the inhaled dose appeared as metabolic products in the urine or as 
expired CO2 . These authors concluded that any toxicological action of the compound may 
be due to the intact molecule itself.
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Schumann et al., (1982) studied the pharmacokinetics of [ C] 1,1,1 -trichloroethane in rats 
and mice following inhalation exposure. They concluded that the.biotransformation of 1,1,1- 
trichloroethane is a saturable, dose-dependent process whicl^^impa^ J ) i t t le  o ^  the overall 
pharmacokinetics of the parent molecule due to the limited extent of its metabolism.
1.6 M ETABOLISM  O F HALOGENOALKANES
1.6.1 GENERAL ASPECTS OF CYTOCHROM E P450
Cytochrome P450 is found mainly in liver microsomal and adrenal mitochondrial 
preparations. However, many other organs contain smaller concentrations. Cytochrome 
P450 is thought to be the terminal electron acceptor of the microsomal electron transport 
chain. Estabrook et al. (1971) suggested a scheme for the microsomal electron transport 
reactions associated with cytochrome P450 as shown in Figure 1.1. The monooxygenation 
of a large number of lipid-soluble organic compounds is catalyzed by oxidised cytochrome 
P450 in liver microsomes. As the primary step in the enzymatic mechanism, formation of 
a cytochrome P450-substrate complex occurs, which is accompanied by a profound spectral 
change (Remmer et al., 1966). The subsequent steps involve electron transfer from NADPH 
to oxygen via cytochrome P450 resulting in an activation of the oxygen molecule to an 
oxenoid species (Ullrich and Staudinger, 1968). Reduction of the cytochrome and oxygen 
activation only occurs after the substrate has been bound to the cytochrome. The attack of 
the active oxygen species at the substrate occurs at C-H, N-H and C = C  bonds or heteratoms 
like nitrogen and sulphur.
/
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Figure 1.1 The Cytochrome P450 Cycle
RH - substrate
RON -hyd'oxylated product
12
The spectral properties of the cytochrome are of particular interest. Carbon monoxide 
ligands to the haem-iron of cytochrome P450 when the latter is chemically reduced with 
sodium dithionite. A peak with, a maximum absorbance at 450nm is developed by difference 
spectrophotometry which forms the basis of the assay of cytochrome P450 (Omura and Sato, 
1964 a, b).
1.6.2 INTERACTION OF HALOGENOALKANES WITH CYTOCHROME P450
The binding of a substrate to cytochrome P450 is normally associated with characteristic 
spectral bindings. Two main types of spectral shifts which occur on the binding of various 
ligands to ferric cytochrome P450 (under aerobic conditions) have been recognised (Jefcoate, 
1978; Schenkman, 1970). The type I binding spectra which is characterized by a spectral 
maximum of 385-390nm and a minimum of about 420nm, is formed as a result of binding 
to the phospholipid portion of cytochrome P450. Such spectra are given by many substrates 
for example, hexobarbital, phénobarbital and aminopyrine with microsomal preparations 
(Remmer er ciL, 1966; 1968). Substrates such as aniline (Schenkman et al, 1967) and some 
other nitrogenous-containing ligands give a difference spectrum which is known as type II 
binding with the peak at 420nm and the trough at about 390-405nm. Schenkman et al. 
(1967) and Schenkman and Sato (1968) suggested that the type II binding occurs through 
binding of the lone-pair of electrons of the nitrogen atom to the haem-iron at the sixth co­
ordinate site. Two other spectral shifts have been recognised as follows: firstly, a mirror 
image of type I, referred to as "reverse type I" which is believed to arise from the 
displacement of an endogenous ligand from cytochrome P450 (Guenthner et al., 1980). 
Alcohol induces reverse type I responses with cytochrome P450 (Diehl et al., 1970);
13
Compounds with low Ks values have higher affinity of binding to cytochrome P450 and hence 
a greater potential for metabolism.
The similarities between Ks and Michaelis constant (Km) for hexobarbital and aminopyrine 
suggested that the binding of substrate to the microsomal cytochrome was an important 
determinant of the kinetics of metabolism for these compounds, and that substrate binding 
preceded enzymatic oxidation (Schenkman et al.,1967). However spectral binding does not 
appear to be an absolute requirement for metabolism (Chaplin and Mannering, 1970).
secondly, that which occurs when cytochrome P450 is in the reduced state characterized by 
two pH-dependent peaks at approximately 430nm and 455nm. Ethyl isocyanide (Omura and 
Sato, 1964) and other isonitriles (Ichikawa and Yamano, 1968) cause Soret bands at 430nm 
and 455nm which have been ascribed to two interconvertible forms of cytochrome P450 
existing in pH-dependent equilibrium (Imai and Sato, 1966).
The affinity of binding of substrates to microsomal preparations can be estimated by 
measurement of the so-called spectral constant (KJ. Generally, the binding affinity has been 
found to increase with hydrophobicity (Jefcoate et al., 1969).
Cytochrome P450 derives its name from the difference spectrum obtained by the addition of 
CO to reduced cytochrome P450, which produces a peak at 450nm. CO is an inhibitor of 
cytochrome P450-dependent reactions and it functions by competitively preventing the 
formation of the oxygen complex of the cytochrome. Several halogenated hydrocarbons are 
known to be reductively dehalogenated by cytochrome P450 under anaerobic conditions 
(Anders and Pohl, 1985). Under these conditions, the first step in this process is the binding 
of the halocarbon to the enzyme at the haem-iron site (Luke et al., 1987). Under reducing 
conditions, and in the absence of molecular oxygen, an electron can be transferred from the 
enzyme to the substrate. It has been suggested that the concentration of oxygen may be quite 
low in the centre of liver lobules (Reiner and Uehleke, 1971). At these low concentrations 
of oxygen the haloalkane can compete effectively for the electrons of cytochrome P450 
(Nastainczyk et al., 1977). In the second step, the reduced halocarbon dissociates to a halide 
anion and a haloalkyl radical. The radical can, after a second reductive dehalogenation, form 
an iron-carbene complex or leave the enzyme and abstract a lipid hydrogen to initiate lipid
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peroxidation and tissue damage. As a result of the hydrogen abstraction, the radical is 
converted to a metabolite which is the reduced, dehalogenated form of the substrate. 
Evidence for anaerobic reduction by halogenated alkanes is obtained by monitoring the Soret 
band in the difference spectra. Formation of a carbene-cytochrome P450 complex leads to 
a Soret band in the range of 450-470nm in the difference spectra. This band was tentatively 
assigned by Ullrich and Schnabel (1973) to a ligand complex of the reduced haem-iron with 
the carbene. Direct evidence for the formation of a dichloro-carbene was obtained by Pohl 
and George (1983) during CCI4 metabolism. It comes from the observation of 1,1-dichloro- 
2,2,3,3-tetramethylcyclopropane, which is thought to arise from a reaction between the 
carbene and 2,3-dimethyl-2-butene.
Spectral shifts have been reported by Wolf er al. (1977) with halogenomethanes which 
contain three or four halogens only, whereas dihalomethane as well as mono-halogenated 
methanes gave no difference spectra indicative of carbenes.
There seems to be a good correlation between the rate of reductive metabolism and the ease 
of electrochemical reduction of the carbon-halogen bond which is known to decrease in the 
order I, Br, Cl, F (Fry, 1972). Hanzlik (1981) concluded that the reduction potential of a 
halogenated compound is an important determinant of whether reductive metabolism will 
occur.
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1.6.3 CYTOCHROME P450-MEDIATED METABOLISM OF HALOGENOALKANES
The metabolism of halogenated alkanes and their fate in the body is largely dependent on the 
structure of the haloalkane. In view of the variety of haloalkanes and their metabolic 
reactions in the body, investigation on their structure-activity relationships are of considerable 
interest.
It is widely accepted that many halogenoalkanes undergo metabolic activation by the 
microsomal mixed-function oxidase system associated with cytochrome P450 of the liver cells 
(Slater, 1972; Recknagel and Glende, 1973; McLean, 1975). There is extensive literature 
on the disposition and metabolic fate of these compounds from which certain conclusions can 
be drawn. Their lipid solubility characterizes them as potential substrates for metabolic 
conversion by the microsomal drug metabolizing system. If the molecule contains a C-H 
bond, the unspecific microsomal system is able to perform C-hydroxylation. In some cases, 
such as in chloroform metabolism, where chlorine atoms are substituents of the same carbon 
atom, an unstable intermediate is formed which eliminates a proton and a halide ion to form 
phosgene (COCL) (Mansuy er al., 1977; Pohl er al., 1977). Chloroform is able to be 
metabolized to chloride ion and CO? by the reaction of phosgene with water (Pohl er al., 
1980). Kubic er al. (1974) reported C-hydroxylation of dichloromethane and formation of 
carbon monoxide by a similar collapse of the product as for chloroform.
Other studies have shown that some halogenated alkanes, such as dichloromethane, are 
metabolized by two major pathways as follows: the first is microsomal C-hydroxylation, as 
described, and the second is a glutathione-dependent cytosolic pathway (Rodkey and Colli son,
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1977; Anders et al., 1977; Ahmed and Anders, 1978; Kubic and Anders, 1978). However, 
some halogenated alkanes, such as chlorodifluoromethane (Peter et al., 1986), underwent no 
detectable metabolism and was completely exhaled. Other workers found that compounds 
such as ethylene dichloride ( 1 ,2 -dichloroethane) is metabolized by two competing pathways 
both of which consume glutathione (D’Souza et al., 1988).
Studies on the metabolism of polyhalogenated methanes in vivo have shown that reduction 
of a C-halogen bond occurs. It has been suggested that the mechanism of CCI4  
hepatotoxicity is not an oxidative but a reductive process which proceeds via chloride 
elimination and radical formation and leads to covalent binding to cell constituents and cell 
necrosis (Wirtschafter and Cronyn, 1964). This reduction in most cases is mediated by 
cytochrome P450, and proceeds similarly to the reduction of nitro or azo compound by this 
enzyme (Gillette et al., 1968; Hernandez et al., 1967). Pretreatment of animals with 
phenobarbitone enhances the toxicity of CCI4 (Mclean and Mclean, 1966; Garner and 
Mclean, 1969; Tuchweber and Kovacs, 1971) which suggests the involvement of cytochrome 
P450.
1.6.4 RO LE O F GLUTATHIONE IN M ETABOLISM  OF HALOGENOALKANES
The tripeptide, glutathione (L-y-glutamyl-L-cysteinyl-glycine; GSH) occurs in animal cells 
and also in most plants and bacteria. GSH functions in the protection of cells against the 
effects of free radicals and of reactive oxygen intermediates (e.g. peroxides) that are formed 
in metabolism. It also functions in the reduction of disulphide linkages of protein and other 
molecules and in the synthesis of the deoxyribonucleotide precursors of DNA. GSH has a
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role in the inactivation of a number of compounds. Several investigators have hypothesized 
that conjugation with GSH can be a detoxification mechanism as well as an excretory 
pathway (Chasseaud, 1973; Mitchell et al., 1976; Kluwe et al., 1981; Burk et al., 1983).
The liver is an important organ of biotransformation and appropriately, hepatic GSH levels 
are relatively high. Measurements of hepatic GSH depletion or even extrahepatic GSH 
depletion can provide a useful indicator of the protective role of GSH against potentially toxic 
foreign compounds. Several procedures for the assessment of lipid peroxidation in vitro have 
been utilized for the measurement, in vivo, of oxidation of lipids; one of which is the total 
GSH and glutathione disulphide (GSSG) content of the tissue. Meister (1983) has outlined 
the enzymatic transport phenomena as well as metabolism of glutathione as shown in Figure 
1. 2 .
Many halogenated hydrocarbons have been reported to lower GSH levels after administration 
to animals. These included halothane and vinylidene chloride which are partly metabolized 
to mercapturic acid derivatives (Rosenberg, 1971). Pohl et al. (1981) found that hepatic 
GSH levels decreased to 30, 59 and 8 8 % of control levels one hour after intraperitoneal 
administration of CHCI3, CBrCl3 or CCI4 respectively to phenobarbitone-pretreated rats. 
These authors concluded that the decrease in GSH levels was due to conversion of these 
compounds to diglutathionyl dithiocarbonate (GSCOSG) which has been identified by high 
pressure liquid chromatography (HPLC). Glutathione S-transferases catalyze reactions 
between GSH and a wide variety of electrophilic compounds of exogenous origin to form 
GSH conjugates. A GSH-reactive electrophilic moiety may be produced from a molecule
18
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Figure 1.2 Outline of GSH Metabolism (based on Meister, 1983)
The cellular turnover of GSH involves its intracellular synthesis from glutamate, cysteine and 
glycine catalyzed by y-glutamylcysteine synthethase (1) and GSH synthethase (2), followed 
by transport of GSH (3) and its conversion by membrane-bound y-glutamyl transpeptidase 
(4) to cysteinylglycine (CysH-Gly) and 7 -glutamyl amino acids. Cleavage of cysteinylglycine 
to cysteine (CysH) and glycine (Gly) may be catalyzed by membrane- bound dipeptidase 
(followed by transport of the free amino acids) or may occur intracellularly after transport 
of the dipeptide (5). Transported 7 -glutamyl amino acids (6 ) are converted by 7 -glutamyl 
cyclotransferase (7) to amino acids and 5-oxoproline; the latter is decyclized by 5- 
oxoprolinase (8 ) to glutamate. Glutathione reacts intracellularly with a variety of compounds 
of exogenous and endogenous origin (X) in reactions catalyzed by GSH S-transferases (9) to 
form GSH S-conjugates. These are transported (10) and follow pathways similar to those 
involved in GSH turnover (4, 6  and 11). S-Substituted derivatives of cysteine are acetylated 
(12) to form mercapturic acids, which are transported out of cells (13). Intracellular GSH 
is converted to GSSG in transhydrogenation reactions (14), in reactions catalyzed by GSH 
peroxidases (15), and by reaction with free radicals (16). GSSG is converted to GSH by 
GSSG reductase (17).
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by another reaction, for example, by activation by microsomal mono-oxygenase to form an 
electrophile which reacts with GSH. This can be exemplified by the metabolism of CHCI3 
to phosgene (Docks and Krishna, 1976; Johnson, 1965) which reacts with GSH (Pohl et al., 
1981).
The role of glutathione is particularly important when the lung is exposed to an oxidant. 
Several workers (Mountain, 1963; Delucia et al., 1975; Menzel, 1971) have demonstrated 
a large decrease in the GSH content of the lungs of animals exposed to ozone. In chronic 
exposures to ozone and other oxidant conditions (Mustafa and Tierney, 1978; Cross et al., 
1977) animals exhibited an increased lung GSH content; such response may be related to 
the phenomena of adaptation tolerance (Mustafa and Tierney, 1978).
Fisher and Kilgore (1988) have studied the tissue levels of GSH following acute inhalation 
of different concentrations of 1,2-dichloropropene. They concluded that the nasal GSH 
content was the first to decrease at the lowest concentration, while the GSH content of the 
heart, liver and testis significantly decreased at the highest concentration. However, Vainio 
et al. (1980) have found no significant changes of GSH content in rat liver after the exposure 
of 1 , 1 ,2 -trichloro-1 ,2 ,2 -trifluoroethane.
Recently Garle and Fry (1989) have described an assay for microsomal mono-oxygenase- 
dependent substrate-mediated depletion of GSH added to a liver microsomal incubation. 
They concluded that this assay may be a useful test for reactive metabolite formation from 
novel xenobiotics.
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1.7 TOXICITY OF HALOGENOALKANES
1.7.1 ANIMAL STUDIES
As most of the chlorofluoralkanes and halogenated hydrocarbons of interest are gases, 
exposures are most likely to occur by inhalation. Early toxicity studies were designed to 
evaluate the effects of short exposures, as might be experienced by man. The Underwriters 
Laboratories carried out simple acute exposures of guinea-pigs at various concentrations of 
the test compounds and classified each compound on a scale running from 1 - 6  where 1  
indicates a highly toxic compound while 6  shows a compound of low toxicity. Table 1.2 
shows this classification applied to two groups of halogenated methanes. Other early work 
was concerned with central nervous effects.
Sayers et al. (1930) continuously exposed dogs and monkeys to dichlorodifluoromethane and 
observed tremors and staggering gait at 20% (v/v). Nuckolls (1933) found inhalation of 5- 
1 0 % (v/v) trichlorofluoromethane for two hours to produce loss of coordination, tremors, 
anaesthesia and convulsions in guinea-pigs; dichlorodifluoromethane was less effective. 
Brenner (1937) found that cats tolerated up to 70% (v/v) dichlorodifluoromethane in the 
atmosphere. Booth and Bixby (1932) investigated dichlorofluoromethane and 
chlorodifluoromethane. Convulsions in mice occurred at 4 and 16% (v/v) respectively and 
death occurred at 20 and 49% (v/v). Chlorofluoromethane was found to be rapidly lethal to 
guinea pigs at lower atmospheric concentrations than dichlorofluoromethane (Henne, 1937).
21
Table 1.2 TOXICITY O F SOM E HALOGENOALKANES (based on 
Clayton, 1967 a)
Chemical Concentration 
(% v /v )
Exposure Period 
(Hours)
Fatal UL^
CCI, 2 . 0 2 . 0 + 3
CCI3 F 1 0 . 0 2 . 0 - 5
CCLF. 2 0 . 0 2 . 0 - 6
CCIF3 2 0 . 0 2 . 0 - 6
CF, 2 0 . 0 2 . 0 - 6
CHC13 2 . 0 2 . 0 + 3
CHCLF 1 0 . 0 1 . 0 + 4-5
CHCIF3 2 0 . 0 2 . 0 - 5
CHF3 2 0 . 0 2 . 0 - 6
1 . Underw riters Laboratories classification .
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It is apparent that the inclusion of one or more fluorine atoms in a molecule causes a marked 
reduction in toxic effects. However, increasing substitution of chlorine for hydrogen first 
reduces toxicity (dichloromethane is less toxic than chloromethane) and then increases it (both 
CCI4 and CHCI3 are more toxic than CHgCy. Also, the toxicity decreases with substitution 
of fluorine for chlorine. Nikitenko and Tolgskaya (1965) suggested that toxicity depended 
to some extent on the chlorine content of compounds, when they studied the toxicity of 1 ,2 - 
dichloro-2-fluoroethane, l-chloro-2,2-difluoroethane and 1,2,2-trifluoroethanein mice. The 
stability of the carbon-fluorine bond and its effect on the toxicity of chloroalkanes may be 
due in part to the alteration of the physical and chemical properties of the molecule.
Lester and Greenburg (1950) found that trichlorofluoromethane, dichlorofluoromethane and
1 -chloro-l, 1 -difluoroethane to be anaesthetics and that no liver damage occurred by their 
inhalation. It was revealed that trichlorofluoromethane was the most toxic of the three to 
rats, 10% (v/v) being lethal within half an hour. Trochimowicz et al. (1977) studied the 
subacute inhalation toxicity of eight fluorocarbons including dichlorofluormethane, 
chlorofluoromethane, ditluoromethane and 1-chloro-l, 1-difluoroethane on the rat. They 
found extensive liver damage due to the dichlorofluoromethane while chlorofluoromethane 
produced moderate damage to kidneys and haemopoietic tissues. Scholz (1962) reported no 
effect on blood, urine or liver on acute and chronic toxicity studies of trichlorofluoromethane 
and dichlorofluoromethane on rats, guinea- pigs, dogs and cats.
The effect of inhalation of trichlorofluoromethane and dichlorofluoromethane on lung 
histology in laboratory animals have been reported by Kiibler (1963), who found no changes 
in the lungs of mice exposed for 24 hours to 1% (v/v) propellant vapours. Prendergast et
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al. (1967) studied long-term continuous chronic toxicity of 1% dichlorodifluoromethane on 
rats, guinea-pigs, dogs and monkeys to assess the possible dangers to humans living in 
confined environment, such as nuclear submarines and space vehicles. These co-authors 
demonstrated that continuous exposure to this compound was more hazardous than repeated 
exposures for 30 days to approximately the same concentration. However, no significant 
effects of toxicity were found. Focal liver cell necrosis in monkeys and liver cell vacuolation 
in guinea-pigs were detected histologically. Jenkins et al. (1970) found similar liver cell 
vacuolation in guinea-pigs after inhalation of lOOOppm trichlorofluoromethane for 90 days 
and increased serum urea nitrogen in dogs. Some histopathological changes including 
vacuolation of liver cells, oedema of the lungs and of brain neurons, and increased 
haemopoiesis of the spleen were reported by Clayton (1966) upon repeated exposure of rats 
to trichlorofluoromethane at 4000ppm, 6  hours a day for 28 days and at 12,000ppm, 4 hours 
a day for 1 0  days.
Chlorinated alkane solvents such as carbon tetrachloride, chloroform and 1,2-dichloroethane 
are well known for their hepatotoxicity (Recknagel, 1967; Irish, 1962). Due to its lower 
systemic toxicity, dichloromethane has replaced these toxic compounds in many applications 
(Klaassen and Plaa, 1967). However, Stewart et al. (1972 a, b) and Fodor et al. (1973) 
reported elevated carboxyhaemoglobin in the blood of man and rats after exposure to 
dichloromethane which suggests that the potential of dichloromethane for systemic toxicity 
may have been underestimated.
On the other hand, the fluorine-containing halogenated alkanes such as 
trichlorofluoromethane and dichlorodifluoromethane were not apparently hepatotoxic (Sayers
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et al., 1930; Nuckolls, 1933; Lester and Greenburg, 1950; Bum et al., 1959; Clay ton, 1960; 
Clay ton, 1966; Clay ton, 1967 a, b). Only mild liver cell vacuolation has been reported after 
exposures to chlorofluoroalkanes at levels that might be encountered by humans (Clayton, 
1966; Prendergast et al., 1967; Jenkins et al., 1970).
Longstaff et al., (1984) studied the genotoxicity and carcinogenicity of some halogenated 
alkanes using assessment by short-term in vitro tests and chronic exposures in rats. These 
co-workers made an observation that among all the compounds studied, chloromethane, 
dichloromethane and vinyl chloride were mutagens. Moreover, they identified 
chlorofluoromethane as an active mutagen and carcinogen in short-term tests. 
Chlorodifluoromethane has been regarded by this group as a mutagen but not apparently a 
potent carcinogen.
1.7.2 HUMAN CASES
Baselt and Cravey, (1968) reported a fatal case of inhalation of a mixture of 
trichlorofluoromethane and dichlorodifluoromethane by a fifteen year old. They concluded 
that death was due to anoxia. Bass, (1970) reported sudden unexplainable deaths in 
American youths, which were associated with inhalation of volatile hydrocarbon solvents 
principally 1,1,1-trichloroethane and fluorinated refrigerants and propellants. The authors 
suggested that the cause of death may have been due to severe cardiac arrhythmia induced 
by the volatile compounds. Stewart et al. (1972 a, b) reported that exposure of human 
subjects to dichloromethane vapour resulted in elevated blood carboxyhaemoglobin levels. 
Due to the hepatotoxicity of chloroform and the explosion hazard with ether, fluorinated
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compounds were investigated for anaesthetic activity, for example, halothane. This has been 
widely accepted in clinical practice, but various reports have linked it with hepatotoxicity 
(Hansen, 1970; Nowill, 1970; Johnston and Mendelsohn, 1971).
1.8 ROLE OF SERUM ENZYME ACTIVITIES IN TOXICITY STUDIES
The use of serum enzyme activities for clinical diagnosis has increased markedly during the 
past years (BergMeyer, 1963; Tietz, 1970; Wilkinson, 1970). The assessment of liver 
function by serum enzyme changes in toxicity studies have been reviewed (Cornish, 1971; 
Grice, 1972; Plaa, 1968). Increases in serum enzyme activities are sensitive indicators of 
tissue damage which can often be detected before other clinical or pathological changes are 
evident. Hence, they can be useful in assessing the various degrees of halogenated alkane- 
induced hepatotoxicity. Boyd, (1988) has reviewed some serum enzymes used in the 
diagnosis of diseases in man and animals. Grice er al. (1971) examined the correlation 
between serum enzymes, isoenzyme patterns and histologically detectable organ damage to 
carbon tetrachloride, mercuric chloride, diethanolamine and thioacetamide. Korsrud et al. 
(1972) reported that serum sorbitol dehydrogenase (SDH) activity was more responsive to 
carbon tetrachloride-induced liver damage than several other enzymes.
Several factors could account for the differences observed during studies in sensitivities of 
the serum enzymes for detecting organ damage. One factor is the intracellular localization 
of the enzyme in the liver cell. Lactate dehydrogenase (LDH) is found only in the cytosol 
of liver, lung and heart cells, while arginase is found in liver cytosol (de’Duve et al., 1962). 
SDH and isocitrate dehydrogenase are mainly found in the cytosol fraction of rat liver (Curtis
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et al., 1972). Alanine transaminase (ALT) and aspartate transaminase (AST) are found in 
both the cytosol and the mitochondrial fractions of rat liver (de’Duve et al., (1962). 
Ornithine carbamoyl transferase is found mainly in the mitochondrial fraction and glutamate 
dehydrogenase (GDH) is found only in the mitochondrial fraction of rat liver (Curtis et al., 
1972; de’Duve et al., 1962).
Other factors that could affect the sensitivity of each enzyme are rates of release into blood 
from damaged cells, rates of turnover in blood and the activity of the enzymes in cells prior 
to damage.
Korsrud et al., (1973) reported that SDH was the most sensitive serum index of liver 
necrosis, when they assessed the sensitivity of several enzymes for detection of liver damage 
in rats. This group concluded that LDH was relatively insensitive due to its high activity in 
serum from control rats.
The manifestations of hepatotoxicity due to inhaled CCI4 in male rats were increased AST, 
ALT activities and decreased activities of a number of liver microsomal enzymes (Rogers et 
a/., 1987).
Paustenbach et al. (1986) have found that SDH is a reliable and accurate tool for assessing 
slight degrees of CCl^-induced hepatotoxicity following repeated inhalation. McSheehy et al. 
(1984) have investigated the correlation between the concentration of the test compound and 
the exposure time using CCI4 as a model for inhalation toxicity. They indicated that the
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toxicity is a function of the concentration of CCI4  in blood, as assessed by serum enzymes 
such as AST, ALT, alkaline phosphatase and LDH to assess biochemical changes.
The interference and alteration of metabolic reactions by toxic agents in lung tissue are 
associated with biochemical changes. However, lung tissue is composed of over 40 different 
cell types held together in a complex supporting structure (Sorokin, 1970), and such cellular 
heterogeneity hampers any attempt to investigate biochemical changes in blood serum 
following toxic lung injury.
1.9 AIMS O F THE PRESENT STUDY
It has been shown that there is a considerable body of literature on the metabolism of 
chlorinated hydrocarbons and some chlorofluoroalkanes and their effect on cytochrome P450 
and drug metabolism. However, the toxicity and pharmacokinetic characteristics of many 
hydrochlorofluorocarbons are poorly understood although many of the polyfluorinated alkanes 
are thought to be of a lower order of toxicity compared to CCI4 and CH 2 CI2 .
This study was done in order to seek correlations between chemical structure and physico­
chemical properties of compounds, their rate of uptake, and rate of appearance of tissue 
damage and toxicity.
Some in vitro studies were also carried out to investigate the binding affinity of the sam e 
series of compounds to cytochrome P450; carried out either under aerobic or anaerobic
28
theconditions. Moreover,;nsame compounds were incubated with GSH and liver microsomes 
from rats pretreated with phenobarbitone to study the formation of reactive intermediates.
Much literature exists upon the parameters mentioned above measured separately. 
Simultaneous measurements which relate all features have not been undertaken. 
Halogenoalkanes have been employed as models to investigate the uptake characteristics, 
indices of toxicity and formation of reactive intermediates arising from the sequential 
replacement of chlorine by fluorine in these compounds. The results obtained were 
compared with various physico-chemical characteristics of the compounds with a view to 
constructing a system of predicting the behaviour of future potential solvents.
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 CHEM ICALS
The standard chemicals used in this study were obtained from the following sources:
Aldrich Chemical Company Ltd., Gillingham, Kent, U.K.
Celite 
Soda lime 
Trichloroacetic acid
2-Vinyl-pyridine
British Drug Houses Ltd. (BDH), Poole, Dorset, U.K.
copper sulphate
DTNB (5,5’-dithio-bis(2-nitrobenzoic acid)
EDTA
eosin
Folin-Ciocalteau phenol reagent
formaldehyde
glycerol
haematoxylin
magnesium chloride
methanol
phenobarbitone
picric acid
potassium chloride
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potassium phosphate 
sodium carbonate 
sodium chloride 
sodium dithionite 
sucrose
Sigma Chemical Company Ltd., Poole, Dorset, U.K.
bovine serum albumin
D-fructose
glucose 6 -phosphate
glucose 6 -phosphate dehydrogenase
glutathione (reduced form)
glutathione reductase
NADH
NADP
NADPH
oxogluturate
triethanolamine
2.2 ANIMALS
Male, University of Surrey-bred, barrier-maintained, closed colony Wistar albino rats (150- 
200g body weight) were used in all experiments. Prior to use, the rats were housed 6  to a 
cage with wood chip bedding and were fed rodent breeding diet No. 1, GLP grade (Special
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Diet Services Ltd., Cambridge, U.K.) and water ad libitum. A 12h light/dark cycle was in 
operation (0700-1900 hours light) at 22°C and 50% relative humidity.
2.3 CHAM BER DESIGN
Exposures were conducted in a closed atmosphere exposure system (Figure 2.1 a, b) similar 
to that used by Gargas et al. (1986), designed by Dr G. Loizou (Department of 
Biochemistry, University of Surrey) and constructed in the Department’s workshop by Mr. 
P. Bishop. The volume of the chamber and peripherals into which a single animal was 
placed was 1.16 litres such that a lower load was imposed on an animal at any initial starting 
concentration with the result that a more marked decline in chemical from the atmosphere 
was measured. Under these conditions exposure times of about 3h were found to be adequate 
for all compounds studied. In addition, this system reveals inter-individual variations in 
initial uptake characteristics of a given compound that may relate to respiratory rate. 
Condensation of water vapour does not pose any problems over this exposure period. The 
atmosphere was circulated with a capex 2D diaphragm pump (Charles Austin, Byfleet, 
Surrey, U .K.) at 800 - 1000ml min k Carbon dioxide was removed with soda lime crystals 
in a scrubber placed in series and on the output side of the chamber, just before entry into 
the gas chromatograph sampling loop. Oxygen was maintained in the system at a 
concentration 20.7-21.0% using an OTOX 90 oxygen monitor (Wessex Power Technology 
Ltd., Poole, Dorset, U.K.). The pressure in the chamber was monitored and varied 
insignificantly from atmospheric pressure. The entire system was made from stainless steel, 
except for a small circular pane of glass 9.5cm diameter on the face of the chamber which 
permitted observation of the rats during the exposure period. The chemical was introduced
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Figure 2.1 Closed Recirculated Atmosphere Exposure System
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as a liquid or as gas through a rubber septum housed in a union-T-piece just before the inlet 
side of the chamber. Heating tape was wrapped around the T-piece and switched on for 
approximately 2 min prior to injection of liquids of lower vapour pressure. The atmosphere 
was analyzed by gas chromatography Imin after injection of the chemical, and every 1 0  min 
throughout the exposure period.
2.4 GAS CHROMATOGRAPHY
A Perkin-Elmer 8500 installed with a programmable automatic gas-sampling valve and a 
0.5ml sample loop maintained at 55°C, was used. A flame ionization detector maintained 
at 250°C was also used with nitrogen as the carrier gas at 10ml min'E A 25-meter Bonded- 
Phase, Aluminium Clad 5.0/xm film thickness BPI capillary column 0.53mm i.d ., 0.78mm
o.d., (S.G.E, Ringwood, Victoria 3134, Australia) was used. The oven temperature for each 
chemical was chosen in order to obtain a retention time between 1.0 and 3.0min.
2.5 KINETIC ANALYSIS OF UPTAKE DATA
Non-specific loss curves were obtained for each chemical by placing the carcass of the rat 
in the exposure chamber and monitoring the atmospheric concentration over a 3h period. 
The first order rate constant obtained for the loss was subtracted from the observed uptake 
curves obtained with live animals in the chamber where appropriate.
The analysis of the data was based on that of Andersen et al. (1980), since the majority of 
uptake curves showed two distinct phases. The initial rapid phase was complete within 40-
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80min and corresponded to the equilibration period between gas and the blood and richly 
perfused tissues. The slow phase corresponded to metabolism and loading into poorly 
perfused tissue which continues after initial blood:gas equilibration is attained. Figure 2.2 
shows compartmental models for the disposition of the gaseous halogenated hydrocarbons.
The corrected uptake data were plotted on a semi-logarithmic scale. Each plot in the uptake 
curves represents data from a single rat. The slope of the latter linear portion of each curve
i.e  the slow phase, was measured to give a rate constant k, with units of min'k The 
instantaneous concentration at 130min was read off directly for each curve and multiplied by ' 
k to give a rate of uptake, the value of which had units of concentration in ppm min'^. The 
latter value was normalized by dividing by the weight of the rat, in kilograms, to obtain the 
' final rate of uptake expressed as ppm kg'  ^ body weight min k The normalized rate of uptake 
values were then replotted as a velocity versus concentration curve. The first order 
component of the total uptake was then subtracted by drawing a line of best fit through the 
points of the three highest concentrations and measuring the slope to give a constant. The 
initial exposure concentrations were multiplied by the constant and the result was subtracted 
from the total uptake values. The data thus generated, represented the saturable component 
of the uptake curves (Anderson et al., 1980).
2.6 PHYSICO-CHEM ICAL PARAMETERS
The molecular descriptors molar polarizability and activation energy, were obtained from 
molecular orbital calculations provided with the kind assistance of Dr D.V. Lewis (School 
of Biological Sciences, University of Surrey). The molecular geometries of the compounds
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Figure 2.2 Models for the Disposition of the Gaseous 
Halogenated Hydrocarbons
Kgb, Kbf, Kbg and KpB are the first order rate constants of the diffusion processes 
indicated by the arrows between the discrete compartments. is the overall rate 
constant for metabolic reactions which are assumed to occur within the well 
perfused tissues.
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were optimized to give the minimum energy conformation using the Newton- 
Raphson/Simplex method based on the COSMIC package written by J.G Vinter, A. Davis 
and M.R Saunders (Smith, Kline and French Ltd.). Molecular orbital calculations by the 
CNDO/2 method of Pople et al. (1965) were also performed on the compounds used 
throughout this thesis using COSMIC. Atomic polarizabilities were calculated according to 
the equation:
a = -4 y  y
where C, and Cj are the orbital coefficients of occupied and unoccupied molecular orbitals 
i and j  with energies E,- and respectively.
A measure of the partition coefficient, log P, was calculated according to the method of 
Hansch and Leo (1979) with kind assistance from Dr B.C. Jones (Pfizer U.K. Ltd., 
Sandwich Kent, U .K.).
2.7 PREPARATION OF MICROSOMAL SUSPENSIONS
Rats were pretreated with sodium phenobarbitone (0.1%) in the drinking water supply for 
7-14 days, or by intraperitoneal injection (lOOmg kg'^ body weight) daily for 3 days. 
Animals were killed by cervical dislocation; the livers rapidly removed and cooled in ice-cold 
1.15% (w/v) KCl. All subsequent manipulations were accomplished at 4°C. The livers
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were scissor-minced and homogenised in 0.25M sucrose using a Potter-Elvehjem glass-teflon 
homogeniser. The suspension was then adjusted to 25-33% (w/v) with the same sucrose 
solution and centrifuged at 10,000gav for 30min. The supernatant obtained was further 
centrifuged at 100,000gav for 60min at 4°C; the cytosolic fraction was discarded and the 
microsomal pellet resuspended in 50mM potassium phosphate buffer, pH 7.25 containing 
20% (v/v) glycerol. This microsomal fraction was then centrifuged at 100,000gav for 
60min; the resulting pellet washed, resuspended in the glycerol buffer above and stored as 
aliquots at -80°C.
2.8 CYTOCHROM E P450
Cytochrome P450 was determined routinely as the reduced carbon monoxide adduct (Omura 
and Sato, 1964). Microsomal fractions were diluted with 50mM potassium phosphate, pH 
7.25, containing 20% (v/v) glycerol to give a suspension of 2-3mg protein ml'L Reduction 
to the ferrous form of the haemoprotein was achieved by the addition of a few milligrams 
of sodium dithionite. The sample was then divided between two cuvettes and a baseline was 
recorded. Carbon monoxide was bubbled through the sample cuvette for approximately 
30sec and then rescanned between 400-500nm. The concentration of cytochrome P450 was 
calculated using the difference absorbance coefficient (450-490nm) of 91mM'^ cm'L
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2.9 BINDING SPECTRA
2.9.1 OXIDISED CYTOCHROM E P450 BINDING SPECTRA
Microsomal suspension (5ml) containing l-4mg ml'^ protein in O.IM phosphate buffer, pH
7.6 was divided between 2.5ml stoppered cuvettes and placed in the forward sample position
in a Uvikon 860 spectrophotometer (Kontron Instruments Ltd., Switzerland). A baseline of
the optical difference between the two cuvettes was recorded at 350nm and 460nm. Substrate
(in methanol) was added in sequential amounts to the sarnple cuvette using a Hamilton 
I  inserted through the stopper to the base of the cuvette. ; 
microlitre syringe^ Equal amounts of methanol were added to the reference cuvette. After
mixing, the optical difference between the sample and the reference was recorded over the
baseline for determination of the wavelengths of spectral maxima and minima. For gases,
samples were removed from the gas sample bags and the required aliquots were removed
using a gas-tight syringe and added to the stoppered test cuvette only. The concentration of
the gas in the sample cuvette was calculated using the ideal gas equation below assuming
that all of the gas (or volatile liquid) was evenly distributed throughout the aqueous microsomal 
phase. As the head-space between the top of the microsomal suspension and the bottom of the 
stopper was negligible, the amount of volatile substrate in this gas phase was also assumed to 
be negligible.
P V = n R T
where R =  the molar gas constant (8.314 J K'  ^ mol'^)
P =  the pressure of the gas (Nm'^)
V =  the volume of the gas (m^) 
n =  the quantity of the gas (mol)
T =  the temperature (K)
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The spectral binding constant, K, was determined by measuring the absorbance change in the 
difference spectrum at a range of substrate concentrations. The total absorbance change 
obtained at each substrate concentration was taken as the sum of the absorbance differences 
between the peak and the baseline on the one hand and the baseline and the trough on the 
other. The results were then presented as a double reciprocal plot.
2.9.2 REDUCED CYTOCHROME P450 BINDING SPECTRA
Spectra were also recorded between 390nm and 500nm as described in Section 2.9.1, but 
after chemical reduction of the microsomal suspensions in both cuvettes with a few 
milligrams of solid sodium dithionite. The baseline obtained with reduced microsomal 
suspensions was level between 430 and 500nm. The spectra will be referred to as reduced 
spectra.
In another experiment, NADPH (100/iM) was substituted for sodium dithionite. The 
experiments were run under anaerobic conditions andThis was achieved using anaerobic 
system model 1024 (Forma Scientific Marietta, Ohio, U .S.A .).
2.10 DETECTION OF CARBON MONOXIDE WITH HAEMOGLOBIN
In order to detect any carbon monoxide formed during anaerobic microsomal incubations 
with NADPH or sodium dithionite, haemoglobin was used for the detection of the carbon 
monoxide-haemoglobin spectrum. Rat haemoglobin was prepared according to the method 
of Rossi-Fanelli and Antonini (1955). Blood taken from rats was immediately diluted with
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2 volumes of 1 % (w/v) NaCl solution and centrifuged at 1000-1500rpm for 10min. The red 
corpuscles separated were repeatedly washed with the NaCl solution and were finally 
haemolysed with an equal volume of distilled water. The extract was filtered upon addition 
of celite and was used as an aqueous solution.
2.11 BIOCHEMICAL METHODS
2.11.1 TOTAL GLUTATHIONE DETERMINATION
Animals were killed 2h after the end of the exposure to halogenoalkanes for the 
determination of tissue total glutathione (GSH +  GSSG). This time was based on literature 
reports of depletion of non-protein sulphydryl levels following oral administration of 1,3- 
dichloropropene (Dietz et al., 1984 b) and similar compounds (Kluwe et al., 1981) and by 
glutathione movement, turnover and metabolism (Meister, 1983; Griffith and Meister, 1979). 
Prior to death by exsanguination the animals were anaesthetized with lOOmg pentobarbital 
kg'^ intraperitoneally and 5ml blood was removed from the abdominal aorta at the iliac 
bifurcation. Blood was allowed to clot at room temperature, then centrifuged at 3000rpm 
for lOmin. The separated serum was stored at -80°C until analyzed. The animals were 
quickly dissected after blood collection. Lungs were perfused in situ and livers were 
perfused through the portal vein with ice-cold, isotonic saline. The assay for total 
glutathione was carried out according to the method of Griffith (1985). A tissue homogenate 
obtained from 0.4-1.0g liver or lung in 5.0 volumes (w/v) of 1% (w/v) picric acid was 
prepared with the use of a motor-driven Potter-Elvehjem homogeniser. This mixture was 
centrifuged at 2000rpm for lOmin at 4°C. The following were then added to 5jul of each
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supernatant: 195^1 distilled water, 100/xl 5,5-dithio-bis-2-nitrobenzoic acid (2.38mg ml'^ in 
0.125mol litre'* phosphate buffer, pH 7.5) and 700/xl NADPH in the phosphate buffer 
solution (0.266mg ml'*). The mixtures were vortexed and allowed to stand for 3min at 
30°C. The reaction was started by the addition of 1 unit of glutathione reductase dissolved 
in 5fji\ of the phosphate buffer. The contents were mixed and the cuvettes were immediately 
placed in a spectrophotometer. The change in absorbance (A) was monitored for 5min at 
412nm and the expression A A/At, was used for the calculations, where t =  time in min. A 
standard plot was constructed using 1,2,3 and 4nmol reduced glutathione and the tissue 
concentration of total glutathione was determined.
2.11.2 GLUTATHIONE DISULPHIDE (GSSG)
The assay was made by reacting the reduced glutathione (GSH) with 2-vinyl-pyridine (2-VP). 
This was done by mixing 100^1 of the protein-free supernatant vigorously with 2/nl neat 2-VP 
and allowing it to stand for 60min at room temperature. An aliquot (Sfxl) of this solution was 
assayed for GSSG. The same procedure as above (section 2.11.1) was followed except that 
for the GSSG measurement, glutathione reductase was increased to 4 units. Again a standard 
plot was constructed for determination of GSSG using 0.2, 0.4, 0.6, and l.Onmol reduced 
glutathione.
The oxidised glutathione concentration was calculated from dividing total glutathione 
concentration obtained by 2 .
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2.11.3 DETECTION OF REACTIVE METABOLITES IN VITRO
The detection of the possible formation of reactive metabolites from halogenoalkanes by liver 
microsomal fractions was carried out according to the method of Garle and Fry (1989).
Liver microsomal fractions from rats pretreated with phenobarbitone were prepared as 
described in section 2.7. The incubation mixture (1ml) contained liver microsomal fraction 
(final concentration 0.75-1.0mg protein ml'*), O.IM phosphate buffer (pH 7.4), 5mM 
MgCl2 , 0.5mM NADP, 5mM glucose 6 -phosphate, glucose 6 -phosphate dehydrogenase (1 
unit ml'*), 200/xM GSH and substrate, added in methanol where these were liquids. The 
haloalkane substrates were added at different concentrations (these are specified later in the 
results chapters) in a volume of 5/xl methanol per ml incubation. The gases were introduced 
into stoppered incubation tubes using the technique described in section 2.9.1. The 
concentration of the gases in the incubation was calculated using the equation quoted in 
Section 2.9.1. The tubes were incubated for 30min at 37°C in a shaking water bath after 
which time the reaction was stopped by the addition of 1 0 % (w/v) trichloroacetic acid ( 1 ml). 
The precipitated protein was removed by centrifugation, and the amount of GSH remaining 
in the protein-free supernatant was measured by the method of Griffith, (1985) as described 
in section 2.11.1. The results obtained were corrected for the depletion of GSH that 
occurred in the absence of substrate; this value represented less than 13% (range 9-15%, 
n = 6 ) of the GSH added. The endogenous GSH content of each microsomal preparation was 
less than 4nmol mg'* protein. This experiment was done both under aerobic conditions and 
in the absence of oxygen using the same system described in Section 2.9.2.
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2.11.4 SERUM ENZYMES
Serum was collected at 2 and 24 hours after the end of exposure to different concentrations 
of the compounds used as described in section 2.11.1. Serum lactate dehydrogenase was 
measured by an automated method (auto analyser model 11) using kits supplied by Roche 
Diagnostica. Serum sorbitol dehydrogenase was determined according to the method of 
Gerlach (1983) and glutamate dehydrogenase activity was measured according to the method 
of Schmidt (1983).
In a preliminary experiment, the effect of storing frozen serum samples at -80°C on the 
activity of SDH was studied. Three rats were injected intraperitoneally with CCI4  in corn 
oil (1:1) at a dose of 1ml/kg and serum was collected after 24h, divided into aliquots and 
SDH activity was determined immediately and then weekly on the stored aliquots at -80°C 
for 20 weeks. No changes were observed in the activity of SDH in sera of rats after 20 
weeks at -80°C. The results after 20 weeks were similar to those obtained after immediate 
collection of sera. Therefore, the lability of SDH reported by Secchi and Ghidoni (1963) at 
0°C was overcome by storing the serum samples at -80°C.
2.11.5 PROTEIN DETERM INATION
The protein concentration of the various hepatic microsomal fractions was determined by the 
method of Lowry et al. (1951) using bovine serum albumin (fraction V) as standard.
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2.12 HISTOLOGICAL STAINING OF TISSUES BY HAEMATOXYLIN AND EOSIN 
(H & E)
Liver, lungs and kidneys were removed and placed in pots containing 10% neutral buffered 
formalin until analysis.
The H & E method of staining was carried out routinely for general screening of all the 
tissues. Haematoxylin has the property of reacting with and binding to acidic groups such 
as are found in nucleic acids. Such components of cells are referred to as ‘basophilic’. In 
acid solution haematoxylin is reddish in colour and soluble; when rendered alkaline, 
haematoxylin turns blue in colour and becomes permanently fixed to the tissue. Eosin is 
used as a counterstain and concentrates mainly in the cytoplasm and other non-nuclear 
components referred to as ‘eosinophilic’ or ‘acidophilic’ areas.
The wax-embedded tissue was placed on a wooden block and 6jjim thick sections were cut 
using a microtome. The wax sections were placed on clean glass slides and dewaxed in 
xylene for 3min before transfer to 100% alcohol for Imin. The slides were then transferred 
into 70% alcohol followed by 50% alcohol for Imin each. At this stage, the slides were 
washed in distilled water before staining in haematoxylin for 15min. Differentiation of the 
tissue was carried out in a 1 % solution of acid alcohol for a few seconds before rinsing in 
tap water for lOmin. The sections were transferred to a 1 % solution of eosin for 2min. The 
slides were then rinsed in water and dehydrated by immersion into 80% alcohol followed by 
100% alcohol for 30sec each. The sections were cleared in xylene and mounted in DPX.
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2.13 STATISTICAL ANALYSIS
The results were presented as the mean ±  S.E.M. Comparison between sets of data were 
performed using Student’s t-test on IBM PC XT computer.
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CHAPTER 3
THE UPTAKE AND METABOLIC EFFECTS OF INHALED 1,1,1-
TRIHALOETHANES
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3.1 INTRODUCTION
1,1,1-Trichloroethane (TCE) is a widely used solvent and is also present in several 
commercial aerosol and adhesive products. Based on its LD 5 0 , TCE is considered to be a 
relatively safe solvent (Goto et al., 1977). However, its primary effect at high dosage is a 
dose-related depression of the central nervous system. The structural analogues of TCE 1,1- 
dichloro-1 -fluoroethane (DCFE), which may be formed in the environment in a 
photochlorination reaction from naturally occuring compounds and exhaust pollutants, could 
have important implications for air pollution and ozone depletion in the upper atmosphere 
(Takizawa and Muto, 1988). 1-Chloro-l, 1-difluoroethane (CDFE) and 1 ,1 ,1-trifluoroethane 
(TFE) have been proposed for refrigerant use, due to their lower ozone depletion potential, 
and also for solvent cleaning of small aluminium capacitors and other electronic components. 
(Makino, 1988; Bivens and Connon, 1981; Hesse and Knise, 1988).
TCE is metabolised . in the rat, but in the human it is taken up rapidly and mostly
exhaled unchanged, although a small percentage of the dose is metabolised to trichloroethanol 
and trichloroethanoic acid (Hake et al., 1960; Stewart, 1968; Monster et al., 1979). There 
is little or no information on metabolism of other fluorinated members of the series.
The present investigation of the uptake characteristics, metabolism and indices of toxicity of 
this series of 1 , 1 , 1 -trihaloethanes was designed to determine the effect o f sequential 
replacement of chlorine by fluorine. The results obtained were compared with various 
physico-chemical characteristics of the compounds with a view to obtaining correlations that 
may have predictive value.
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3.2 M ATERIALS AND M ETHODS
3.2.1 M ATERIALS
All materials were obtained as described in Chapter 2. TCE minimum assay (GLC) 99% 
was obtained from BDH Ltd., Poole, Dorset. DCFE, CDFE and TFE were obtained from 
Fluorochem Ltd., Old Glossop, Derbyshire. CDFE and TFE are gases at room temperature 
and, therefore, they were sampled by filling gas sample bags (SKC Inc., PA 15330 USA) 
and the required aliquots were removed using a gas-tight syringe.
3.2.2 EXPERIM ENTAL DESIGN
Rats were exposed for 3h in a closed atmosphere exposure system to a range of atmospheric 
concentrations of the chemicals (Table 3.1) as described in Chapter 2, Section 2.3.
SAMPLING
Animals were anaesthetized and killed 2 and 24h after exposure. Blood samples were 
collected and allowed to clot. Serum was separated and stored at -80°C until analyzed. 
Lactate dehydrogenase, sorbitol and glutamate dehydrogenase were determined using standard 
procedures as described in Chapter 2, Section 2.11.4. In animals which were killed 2 hours 
after exposure, liver and lungs were collected immediately and total and oxidised glutathione 
in these tissues were determined according to the methods described in Chapter 2, Sections
2 . 1 1 . 1  and 2 . 1 1 . 2  respectively. ‘
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Table 3.1 CONCENTRATION O F A T M O SPH E R IC E X PO SU R E SO Fl,1,1- 
TRIHALOETHANES
Chemical
Atmospheric concentration (ppm x 1 0 ')
4 8 1 0 15 2 0 30 40
CCI3 CH3 / / nd nd / / /
CCI2FCH3 / / nd nd / / /
CCIF2 CH3 nd / / / / / nd
CF3 CH3 nd nd / / / / nd
/  concentration used
nd not done
6  rats w ere used for each concentration
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3.2.3 HISTOLOGY
Pieces of liver, kidney and lungs were fixed in 10 per cent formol-saline and paraffin 
sections 6 /im thick were cut and stained with haematoxylin and eosin (H & E) as described 
in Chapter 2, Section 2.12.
3.2.4 INTERACTIONS W ITH HEPATIC M ICROSOM AL FRACTIONS 
BINDING SPECTRA W ITH OXIDISED M ICROSOM ES
Interaction of the compounds with oxidised cytochrome P450 in the presence of O2  was 
studied. The spectral binding constant (KJ and maximum absorbance change (AA^aJ were 
determined by measuring the absorbance change in difference spectra at a range of substrate 
concentrations in hepatic microsomal fraction from phenobarbitone-induced rats, as described 
in Chapter 2, Section 2.9.1.
BINDING SPECTRA W ITH REDUCED M ICROSOM ES
These were recorded after reduction of the microsomes with sodium dithionite or NADPH 
under anaerobic conditions as described in Chapter 2, Section 2.9.2. At the end of the 
experiment, CO was bubbled in the test cuvette for examination of the magnitude of the 
cytochrome P450-CO spectra. In other experiments, Hb was added to reduced microsomes 
in equal amounts to the test and reference cuvettes as described in Chapter 2, Section 2.10.
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3.2.5 DETECTION OF REACTIVE METABOLITES
The 1 ,1 ,1-trihaloethanes were incubated with microsomes from phenobarbitone-induced rats, 
in the presence of a NADPH generating system and reduced glutathione under either aerobic 
or anaerobic conditions. The ability of these compounds to deplete GSH was studied 
according to the method described in Chapter 2, Section 2.11.3.
3.3 RESULTS
3.3.1 PHYSICO-CHEMICAL PROPERTIES OF THE 1,1,1-TRIHALOETHANES
Table 3.2 summarizes the molecular descriptors, molar polarizability (amol) and activation 
energy (AE), as well as the calculated partition coefficient, C log P. The values of am ol and 
C log P decreased with increasing fluorine content while AE increased with increasing 
fluorine content.
3.3.2 THE UPTAKE OF TRIHALOETHANES
The uptake curves of TCE and DCFE were characterized by an initial rapid uptake phase 
followed by an essentially first order phase (Figure 3.1). The magnitude of the initial phase
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Table 3.2 P H Y S I C O - C H E M IC A L  P R O P E R T I E S  O F  1 ,1 ,1  
TRIHALOETHANES
Compound amol
(A')
AE*
(eV)
Log P 
(calculated)
CCI3 C H 3 6 . 6 6 1 4 .6 - 2 .4 8 1
C C I3F C H 3 5 .8 8 1 5 .0 2 .0 4 1
C C IF 3 C H 3 5 .1 0 1 6 .3 1 .6 0 1
C F 3 C H 3 4 .4 6 2 2 . 8 1 .1 6 1
1.
AE
H O M O
LEM O
difference betw een  E (H O M O ) and E (L E M O ) 
highest occupied  m olecu lar orbital 
low est em pty m olecular orbital
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( A ) 1,1,1-Trichloroethane
C o n c en t ra t io n  (ppm)
1 0 0 0 0 0  r
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1 0 0
250 3 0 02001500 50 100
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—— 4 0 0 0 0  ppm —— 3 0 0 0 0  ppm 2 0 0 0 0  ppm
- 3 -  8 0 0 0  ppm —  4 0 0 0  ppm —^  20 0 0  ppm
( B )  i, i-D ic h !o ro -1 -F lu o ro e th a n e
C on c en t ra t io n  (ppm)
1 0 0 0 0 0
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■s-c
1000
1 0 0
200 2 50150100500
3 0 0 0 0
4 0 0 0
Time (minutes)
— (—  20000  
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8 0 0 0
( C )  1-Chloro-l,1-di f luoroethane
C onc en t ra t io n  (ppm)
(D ) 1,1,1-Trifluoroethane
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2 500 20050 150100
3 0 0 0 0  ppm 
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1 0 0 0 0 0
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3 0 0 0 0  ppm 
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—><- 6 0 0 0  ppm
15000  ppm
Figure 3.1 The Uptake Curves of 1,1,1-Trihaloethanes
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declined markedly with increasing fluorine content. Analysis of the first order phases 
showed they consisted of a summation of a saturable component (presumed to be metabolism) 
and a linear uptake component for both TCE and DCFE (Figure 3.2). There was no 
evidence for a saturable metabolic component for CDFE and TFE at the concentrations used.
Considering the 3 hour time point only (Figure 3.3), there was a linear relationship between 
the amount of compound in the animal and the concentration remaining in the atmosphere 
over the concentration range 0-16,000 ppm. The slope of the lines decreased with increased 
fluorine content and gave reasonable linear correlations with calculated log P (lipid/water 
partition coefficient), r =  0.99, P <  0.01 (Figure 3.4) and amol (Figure 3.5). No simple 
relationship exists between activation energy (AE) and the slopes of the plots of amount 
retained by animal and the amount remaining in the chamber atmosphere.
TISSUE GLUTATHIONE DEPLETION
None of the compounds altered the glutathione status of the lung significantly (Figure 3.6), 
but all four compounds depleted the total glutathione content of the liver (Table 3.3). The 
initial concentration required to produce a detectable decrease in liver total GSH increased 
with increasing fluorine content. Total GSH depletion appeared to relate approximately to 
the total body burden of the compounds (Table 3.3). The concentrations of GSSG in liver 
and lungs were not altered in all compounds tested (Table 3.4 a and b).
56
( A )
R ate o f U ptake  o f 1,1,1-Trichloroethane
V ersus  C onc en t ra t ion  
Rate  of Uptake  (ppm/kg/min)
50
4 0
3 0
20
5020 30 400 10
Initial E x p o su re  Level (ppm) (Thousands)
- Total Uptake  S aturab le  metabolism
Rate of Uptake of 1,1-Dichloro-l-Fluoro- 
e th a n e  Versus C o ncen tra t ion
Rate of Uptake (ppm/kg/min)
1
60
40
20
5020 30 400 10
Initial E xposure  Level (ppm) (Thousands)
■ Total Uptake S a tu rab le  m etabolism
( C )
Rate of Uptake of 1-Chloro-1,1-Difluoro 
e t h a n e  V ersus C oncen tra t ion
6 0 ,
Rate of Uptake  (ppm/kg/min)
5 0
4 0
3 0
20
12 168 10 140 2 4 6
Initial E x p o su re  Level (ppm) (Thousands)  
^ Total Uptake
(D)
Rate of Uptake of 1,1,1-Trifluoroethane 
Versus C o ncen tra t ion
Rate of Uptake (ppm/kg/min)
1 0 0 -
80
60
40
20
0 2 6 8 12 164 10 14
Initial Exposu re  Level (ppm X Thousands)  
^ Total Uptake
Figure 3.2 The rate of Uptake of 1,1,1 -Trihaloethanes
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1,1,1-Trichloroethane
Total g lu tath ione content (pm ol/g lung)
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Concentration ( ppm )
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Figure 3.6 Total Glutathione Content in the Lungs 
after a Three Hour Exposure to 1,1,1-Trihaloethanes
Each v a lu e  r ep resen ts  th e  m ean  o f 3 or 4 rats ± S .E .M .
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3.3.4 SERUM ENZYMES AND HISTOLOGY
There were no detectable changes in serum enzyme activities nor any histopathological 
changes in liver, lung and kidneys (data not shown) of experimental animals for any of the 
compounds at any of the exposure levels tested.
3.3.5 SPECTRAL INTERACTIONS W ITH HEPATIC M ICROSOM AL FRACTIONS
The binding spectra o f the four compounds with microsomal preparations from 
phenobarbitone-induced rats were examined. They all displayed a type I interaction, 
exhibiting peaks at about 385-388nm and troughs at about 420nm. Analysis of the binding 
spectra yielded the spectral binding constants, and AA^ax, presented in Table 3.5. The 
Kg values increased with increasing fluorine content while decreased with increased 
fluorine content. Both Kg and AA^ax values gave a positive linear correlation with calculated 
log P (r =  0.9; Figure 3.7 a and b). The binding spectra for CF3CH3 was too small to allow 
the Kg value to be calculated.
Upon reduction of the microsomal suspension with sodium dithionite and addition of TCE, 
the type I difference spectra was abolished and two peaks at approximately 423 and 464nm 
were recorded after 5min (Table 3.6). The peak at 423nm decreased but that at 464nm 
increased with time. When CO was bubbled in the test cuvette at the end of the experiment, 
the P450-CO spectrum was reduced by 35 % in comparison with a control incubation in the 
absence of TCE.
65
Table 3.5 CONSTANTS DERIVED FROM THE BINDING SPECTRA OF 1,1,1- 
TRIHALOETHANES
Chemical Kg (mM) ^ ^ m a x
CCI3 C H 3 0 .6  +  0 .0 4 0 .0 8
CCI2 F C H 3 1 .0 3 + 0 .1 2 0 .0 6
C C IF 3 C H 3 9 . 1 + 0 .7 0 .0 5
C F 3 C H 3 - 1 (0 .0 3 ) :
1 T he difference w as very  sm all; no value for K, could  be determ ined,
2  This w as the m axim um  absorbance observed and w as obtained with the first a liquot o f
substrate added.
E ach value is the m ean o f  three determ inations ±  S .E .M .
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R = 0.97- 1.0
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Calculated logP
b- Relationship Between Calculated LogP and AAmax for 1,1,1-Trihaloethanes
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Table 3.6 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS
OF 1,1,1-TRIHALOETHANES w it h  s o d iu m  DITHIONITE- 
REDUCED RAT MICROSOMAL FRACTIONS
Chemical Final Concentration (mM) Spectral Maxima (nm)
CCI3CH3 1 4 2 3  and  4 6 4
CCI3FCH3 1  and 5 4 2 6  and 4 6 7 ’
CCIF3CH3 2 446=
CF3CH3 2 4 4 4
1  sm all
2  very  sm all
68
DCFE also yielded, a reduced spectrum with chemically reduced microsomes. The peak was
smaller than that produced by TCE with its maximum at 467nm, reaching its full magnitude
in the
within lOmin (Table 3.6). No reduction^P450-CO peak was observed at the end of the 
experiment.
Figure 3.8 shows the rate of formation of these reduced spectra with TCE (ImM) and DCFE 
(1 and 5mM).
CDFE and TEE were found to interact with reduced microsomes giving very small peaks at 
446 and 444nm respectively (Table 3.6). There were neither decreases in P450-CO peak nor 
time-dependent formation of spectra with these compounds.
TCE also interacted with NADPH-reduced microsomes under anaerobic conditions giving 
peaks at 398 and 452nm as well as a trough at approximately 420nm (Table 3.7). The 
spectrum at 452nm which is time-dependent reached its maximum within 25-30min while the 
398nm peak diminished with time.
Figure 3.9 shows that the rate of formation of NADPH-reduced spectra in microsomes from 
phenobarbitone-pretreated rats under anaerobic conditions with TCE was not concentration- 
dependent. As in sodium dithionite-reduced microsomes, addition of sodium dithionite and 
bubbling o f CO in the test cuvette, resulted in a 35% decrease in the P450-CO spectrum 
determined at the end of the experiment compared with a control experiment in the absence 
of TCE.
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0 .0 5 •  CH_CC1« (ImM)-peak at464nm
0 .0 4
0 .0 31
<<
0.02
C H gC C l^ (5mM)-peak at 467nm
0.01
CHgCCljF (ImM)-peak at 467nm
0.00
0 10 20
T i m e ( m i n )
Figure3.8 Rate of Formation of the Spectral Peak with 1,1,1-Trihaloethanes 
and Rat Microsomal Fraction Reduced with Sodium Dithionite
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Table 3.7 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS OF
1,1,1-TRIHALOETHANES WITH NADPH-REDUCED RAT 
M ICROSOM AL FRACTIONS UNDER ANAEROBIC  
CONDITIONS
C h em ical F in a l C oncentration  (m M ) Spectral M a x im a  (nm )
CCI3 C H 3 1 and 5 3 8 9  and 4 5 2
CCI2 F C H 3 5 3 8 9
C C IF 3 C H 3 2 3 8 6
C F 3 C H 3 2 4 1 6
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Figure3.9 Rate of Formation of the Spectral Peak with 1,1,1-Trichloroethane 
and NADPH-Reduced Microsomal Fraction under Anaerobic Conditions
72
DCFE and CDFE gave spectra indicative of type I binding spectra with peaks at about 
389nm and troughs at 420nm (Table 3.7). Unlike TCE, the rate of formation of those 
peaks was not time-dependent. The final P450-CO spectrum was not altered with these 
two compounds.
TEE also interacted with NADPH-reduced microsomes giving a peak at 416nm and a 
trough at 443nm (Table 3.7) which disappeared after 5min with no further development. 
The final P450-CO peak was not altered.
After reduction of the microsomes with either sodium dithionite or NADPH and addition 
of trihaloethanes, the time-dependent peaks mentioned above, were observed. When 
haemoglobin was added to both cuvettes, no other peaks were observed.
DETECTION O F REACTIVE M ETABOLITES
When trihaloethanes were incubated with liver microsomes, a NADPH generating system 
and GSH in the presence of O2  at 37°C, there was no change in GSH concentrations in 
comparison with control incubations. Under anaerobic conditions, incubation of liver 
microsomes from rats pretreated with phenobarbitone with trihaloethanes led to GSH 
depletion (Table 3.8). The depletion was appreciably higher with TCE and DCFE than 
with CDFE and TEE. Omission of the NADPH generating system effectively abolished
this depletion] (data not shown).
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Table 3.8 GSH DEPLETION WITH 1,1,1-TRIHALOETHANES UNDER
ANAEROBIC CONDITIONS
Chemical GSH Depletion (nmol/mg protein/SOmin)
C ontrol 0
T C E  (lO m M ) 2 7  ±  1 .2
D C F E (lO m M ) 3 0  ±  1.1
C D F E (3 m M ) 9 +  1.1
T F E  (3 m M ) 8 ±  1 .3
Each value represents results from 6  incubations ±  SE M  with liver  m icrosom es from  rats treated w ith  
phenobarbitone. Control value represents incubation m ixture w ithout substrate w h ere no lo ss  o f  G SH  
occurred .
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3.4 DISCUSSION
In this study a saturable component of the uptake of TCE was observed which is not counter 
to the results obtained by Gargas et al. (1986) who used a very low range of exposure 
concentrations (0.2 - 210ppm). This range of concentrations fell well within the linear first- 
order portion of uptake of TCE (Figure 3.1). Schumann et al. (1982) confirmed that 
although TCE appears to be a poor substrate for oxidative metabolism in rodents (Hake et 
al., 1960; Monster et al., 1979), it is a saturable dose-dependent process. TCE and DCFE 
were taken up rapidly across the air: alveolar interface which could be attributed to their 
substantial lipophilicity which could favour diffusion through this barrier. A linear 
correlation was found between uptake of trihaloethanes and log P and amol. Moreover, a 
positive reasonable linear correlation was found between the calculated log P values of 
trihaloethanes and their and AA^^x values. This correlation between the biological data 
and the physico-chemical characteristics of these compounds possibly suggests a structure- 
activity relationship for 1 , 1 , 1 -trihaloethanes.
The depletion of GSH by trihaloethanes in vivo could be explained by the metabolism of TCE 
to 1 , 1 , 1 -trichloroethanol and in the possible pathway to 1 , 1 , 1  -trichloroethanoic acid reported 
by Hake et al. (1960) and Stewart (1968) as shown in Figure 3.10. Schumann and co­
workers (1982) estimated that 6 % of the inhaled dose was metabolized. In addition, Bogen 
and Hall (1989) observed some metabolism to 1 ,1 ,1-trichloroethanol, glucuronide and COj. 
A possible scheme is proposed which suggests that chloral, the intermediate produced by the 
action of alcohol dehydrogenase on the 1 ,1 ,1-trichloroethanol, which is the product of P450
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metabolism, may react with GSH and/or be metabolized by aldehyde dehydrogenase to 1,1,1- 
trichloroethanoic acid (Figure 3.10).
The exposure concentrations required to produce total GSH depletion increased with 
increasing fluorine substitutions possibly reflecting the dependence of uptake on lipid 
solubility. Data obtained with DCFE would suggest a similar reaction scheme (Figure 3.11) 
to that of TCE with the production of 1,1-dichloro-l-fluoroethanol and 1,1-dichloro-l- 
fluoroethanoic acid. Depletion of liver total GSH with this compound at higher concentration 
than TCE may suggest that even less than 6 % of the inhaled dose was metabolized. This 
decreased metabolism would be consistent with reduced log P and otmol values and lower 
affinity of binding with microsomes than TCE.
The GSSG values did not increase which suggests that the depletion of total GSH was not 
due to oxidation of GSH, but possibly due to metabolism of these compounds. However, 
the experimental procedure may have failed to detect changes in GSSG, as this product is 
rapidly removed from the liver via the bile (Grafstrom et al. , 1980) and/or its degradation 
may occur due to the activity of NADPH-dependent GSSG reductase (Meister, 1983). Total 
GSH concentration in the lungs was unchanged for this series possibly due to the rapid 
transport of the chemicals from the lungs(Dallas et a / . / 1989) and the very low P450 content 
o fth iso rganr- . . -  - '
Trihaloethanes failed to produce depletion of GSH in vitro aerobically although they were 
found to bind to cytochrome P450 giving a type I binding spectra. This was not surprising 
and could be explained by the dependence of subsequent metabolism (Figure 3.10) on the
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CC13CH3
P450
CCI3CH2OH glucuronide +  CO;
c y t o s o l i c  a l c o h o l  
d e h y d r o g e n a s e
H
C C L C -O H
G S
GSH
CCI3 C H O
( c h l o r a l )
H ,0
H
C C L C -O H
O H
a l d e h y d e
d e h y d r o g e n a s e
C C L C O O H
Figure 3.10 The Metabolism of 1,1,1-Trichloroethane
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P450
C C L F C H , C C 1 ,F C H ,0 H
c y t o s o l i c  a l c o h o l  
d e h y d r o g e n a s e
H
C C L F C -O H
GSH
C C L F C H O
H ,0
H
C C L F C -O H
G S OH
a l d e h y d e
d e h y d r o g e n a s e
C C L F C O O H
Figure 3.11 Proposed Scheme for the Metabolism of 1,1-Dichloro-l- 
fluoroethane
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presence of cytosolic alcohol dehydrogenase.
The lack of depletion of GSH observed may be due to the absence of any contaminating 
cytsolic alcohol dehydrogenase activity in the washed microsomal suspension. Comparable 
results were obtained by Garle and Fry (1989) when they incubated iproniazid and 
naphthalene with microsomal fraction and GSH in vitro. Both compounds have been shown 
to bind covalently to rat microsomal protein, but efficient conjugation of the reactive 
metabolites with GSH takes place only in the presence of cytsolic GSH transferases 
(Spearman et al., 1984; Buckpitt et al., 1984).
Under anaerobic conditions, trihaloethanes depleted GSH, the more lipophilic the compound 
is, the higher the ability to deplete GSH. Such depletion was dependent on MFO metabolism 
as indicated by omission of NADPH generating system which suggests an activation of 
trihaloethanes (TCE and DCFE) to reactive metabolites. A similar conclusion was made by 
Garle and Fry (1989) who distinguished substrates which interacted directly with GSH from 
those which formed reactive metabolites with P450.
These results coupled with the formation of new time-dependent spectral peaks with either 
sodium dithionite or NADPH-reduced microsomes under anaerobic conditions suggest some 
reductive metabolic changes for TCE and DCFE. The formation of spectral peaks in the 
region of 450-470mm under anaerobic and reducing conditions has been attributed to 
carbanion and carbene formation (Wolf et al., 1977; Ullrich et al., 1978). A radical or 
carbene may be postulated for TCE and DCFE reductive metabolism as follows:
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CC13-CH3 [CC1 3 -CH 3 ]'
cr
P450
CCI2-CH3
( r a d ic a l )
Cl
CH,-C-H
SG
P450
GSH Cl-
:CC1 CH 3
( c a r b e n e )
CCI2CH3
( c a r b a n io n )
Further studies are required to determine the metabolites formed under anaerobic and 
reducing conditions with the trihaloethanes.
The destruction of microsomal protein by addition of NADPH to incubation mixture 
containing TCE under aerobic conditions previously reported by Fioracci and co-workers, 
(1988) was confirmed in the present study. Reduction in P450-CO peak when TCE was 
added to reduced liver microsomes from phenobarbitone-treated rats may be attributed to the 
destruction of P450. This destruction could be attributable to radical formation. No effect 
on the P450-CO peak was observed with the other members of the group.
The formation of CO after addition of the trihaloethanes to sodium dithionite or NADPH- 
reduced microsomes was not observed since addition of Hb to test and reference cuvettes 
failed to produce carboxyhaemoglobin. The purpose of investigating the possibility of CO
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formation was to determine whether the cleavage of C-C bond occurred as a result of 
microsomal metabolism. Such a cleavage might occur at some stage in the metabolism of 
TCE since CO 2  is a human metabolite in vivo. That no carbon monoxide was formed in the 
case of in vitro reductive metabolism can be explained by the difficulty of hydrolysing the 
corresponding carbene complex. Comparable results were obtained by W olf et al. (1977) 
on the reductive metabolism of CCI3CN.
The trihaloethanes at the concentrations used and after 3 hours exposure, did not produce 
hepato-renal or lung damage. This was confirmed by lack of significant changes in serum 
enzyme levels and histopathological lesions. Similar findings were obtained by Klaassen and 
Plaa (1966) and Gehring (1968). These co-workers ranked TCE the least likely to produce 
liver dysfunction among several chlorinated hydrocarbons following intrapertoneal 
administration or inhalation exposures.
The low order of hepatotoxicity of TCE as reported by Schumann et al. (1982) compared to 
some other chlorinated hydrocarbon solvents may be due to the limited extent of 
biotransformation in rodents and man.
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CHAPTER 4
STUDIES ON SOME METABOLIC EFFECTS OF INHALED
DIHALOMETHANES
82
4.1 INTRODUCTION
Dichloromethane (CH 2 CI2 ) is a volatile liquid used as a solvent in a wide variety of industrial 
applications. Due to its lower systemic toxicity, CH2 CI2  has replaced the more toxic 
compounds such as carbon tetrachloride (Klaassen and Plaa, 1966; 1967). However, Stewart 
et al., (1972 a, b), reported elevated carboxyhaemoglobin following human inhalation 
exposures to CH 2 CI2 . Rats exposed by inhalation to 20% (v/v) difluoromethane (CH 2 F 2 ) for 
various periods showed neither biochemical nor histopathological changes which could be 
related to the compound (Trochimowicz et al., 1977). However, these authors reported 
moderate toxic effects in rats after inhalation of 1% (v/v) chlorofluoromethane (CH 2 CIF).
Both in vitro and in vivo studies have indicated that dihalomethanes such as CH 2 CI2  are 
metabolized by two major pathways: an oxidative, cytochrome P450-mediated pathway that 
yielded CO only, and a glutathione-dependent one that yielded CO 2  (Rodkey and Colli son, 
1977; Anders et al., 1977; Ahmed and Anders, 1978; Kubic and Anders, 1978). W olf et 
al., (1977) reported that dihalomethanes, unlike those containing three or four halogens, 
formed no complexes with reduced cytochrome P450. Reports on the metabolism of the 
fluorinated analogues of CH2 CI2  are scarce.
This present study was performed to document fully the uptake and metabolic effects of 
CH 2 CI2  and its fluorinated analogues. The in vivo and in vitro experimental results were 
correlated with the physico-chemical properties of the compounds.
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4.2 MATERIALS AND METHODS
4.2.1 M ATERIALS
All materials were obtained as described in Chapter 2. CH2 CI2  of Analar grade and 
minimum purity 99.9% was supplied by BDH Chemicals (Poole, Dorset, England). CH 2 FCI 
and CH 2 F 2  were supplied by Fluorochem Ltd., Old Glossop, Derbyshire. CH2 FCI and 
CH 2 F 2  are gases at room temperature and therefore they were sampled by filling gas sample 
bags (SKC Inc. PA 15330 U .S.A .). The required aliquots were removed using a gas-tight 
syringe.
4.2.2 EXPERIM ENTAL DESIGN
Rats were exposed for 3 hours in a closed recirculating atmospheric exposure system to a 
range of atmospheric concentrations of the chemicals (Table 4.1) as described in Chapter 2, 
Section 2.3.
SAMPLING
Animals were anaesthetized and killed 2h and 24h after exposure. Blood samples were 
collected and allowed to clot. Serum was separated and stored at -80°C until analyzed. 
Lactate dehydrogenase, sorbitol dehydrogenase and glutamate dehydrogenase
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were determined using standard methods as described in Chapter 2, Section 2.11.4. Liver 
and lungs were removed immediately from animals which were killed 2 h after exposure. 
Total and oxidized glutathione in lung and liver were determined according to the methods 
described in Chapter 2, Sections 2.11.1 and 2.11.2 respectively.
4.2.3 HISTOLOGY
Portions of liver, kidney and lungs were fixed in 10 per cent formol-saline and paraffin 
section 6 /xm thick were cut and stained with haematoxylin and eosin (H & E) as described 
in Chapter 2, Section 2.12.
4.2.4 INTERACTION W ITH HEPATIC M ICROSOM AL FRACTIONS 
BINDING SPECTRA W ITH OXIDISED M ICROSOM ES
Interaction of the compounds with oxidised cytochrome P450 maximum absorbance change 
380-420 (AAmax) in the presence of O2  was studied. The spectral binding constant (KJ were 
determined by measuring the absorbance change in difference spectra after sequential addition 
of the substrate to hepatic microsomal fraction from rats pretreated with phenobarbitone as 
described in Chapter 2, Section 2.9.1.
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BINDING SPECTRA WITH REDUCED MICROSOMES
These were recorded after reduction of the microsomes with sodium dithionite or NADPH 
under anaerobic conditions as described in Chapter 2, Section 2.9.2. At the end of the 
experiment CO was bubbled in the test cuvette for examination of cytochrome P450-CO 
spectra. In another experiment Hb was added to reduced microsomes in equal amounts to 
both test and reference cuvettes for detection of any CO formation as described in Chapter 
2, Section 2.10.
4.2.5 DETECTION OF REACTIVE METABOLITES
Dihalomethanes were incubated with microsomes from phenobarbitone-induced rats, NADPH 
generating system and reduced glutathione under either aerobic or anaerobic conditions. The 
ability of these compounds to deplete GSH was studied according to method in Chapter 2, 
Section 2.11.3.
4.3 RESULTS
4.3.1 PHYSICO-CHEMICAL PROPERTIES OF DIHALOMETHANES
Table 4.2 shows the values of molar polarizability (amol), calculated log P and activation 
energy (AE) for CH 2 CI2 , CH 2 CIF and CH 2 F 2 . The calculated log P and am ol values 
decreased with increasing fluorine content which suggests that with dihalomethanes, lipid
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Table 4.2 PHYSICO-CHEM ICAL PROPERTIES O F DIHALOM ETHANES
amol
Compound (Â)
AE
(eV)
Log P 
(calculated)
C H .C L  3 .9 0 15.5 1 .2 4 9
C H ,FC 1 3 .2 1 1 6 .7 0 .8 0 9
C H .F . 2 .6 0 2 2 .9 0 .3 6 9
AE =  E(H O M O ) - E (L E M 0 )
H O M O  =  highest occupied  m olecu lar orbital 
LE M O  =  low est em pty m olecular orbital
eV  =  electron volts
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solubility of the compound increased with increasing chlorine content. In contrast, the 
activation energy values decreased with increasing chlorine content.
4.3.2 TH E UPTAKE O F DIHALGMETHANES
The uptake curves of dihalomethanes are represented in Figure 4.1. The initial uptake phase 
of CH 2 CI2  which was more rapid compared to its fluorinated analogues CH 2 FCI and CH 2 F 2 , 
followed by a first order phase. At all but one of the exposure concentrations, there was 
evidence of a decline in the first order rate at around 2 hours of exposure. Analysis of the 
first order phase revealed contributions from both first order and saturable metabolic pathway 
(Figure 4.2). The behaviour of the uptake curve of CH2 FCI was consistent with a main first- 
order pathway and a metabolic phase. CH 2 F 2  shows a first order phase and an evidence for 
a very minor saturable metabolic component.
After three hours exposure, there was a linear relationship between the amount of compound 
in the animal and the concentration remaining in the atmosphere over the concentration range 
used for each of the three compounds (Figure 4.3). The slope of the lines decreased 
markedly with increased fluorine content giving a significant simple relationship with 
calculated log P and amol (r =  1.0, P <  0.001; r =  0.998, P < 0.001 respectively) (Figure 
4.4). No simple relationship was observed between the ratio of the amount remaining in 
animal/concentration in atmosphere and AE.
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Figure 4.1 The Uptake Curves of Dihalomethanes
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91
rc
E
1
I
s3
2 .
0 
" 1
o\
s
g
C
1
S
w  
>  550il
5 - Ê
0 0c
rt>
§
>
te s -
i .gy* fD
Q "rt>
I I3T
6 ^  S
I | .
f |
n> 35c/5 3  
CL
Amount retained in animal 
(atmospheric ppm equivalents)
i
ro
I
CO
I I
cn
§
>
Bo
T i
3o
n
3
CJl
o
o
cn
o
N>
o
I I
n
sK>
92
^  2
Ea
. c
R = 1.000
CH Cl
— u
c 1
CH CIFco
a 0
cooc
S -1
CH F
D)
-2
0.80.2 0 . 4 0.6 1.0 1 . 2 1 .4
c log P
a- Relationship Between Amount in Animal 
and Remaining in Atmosphere and LogP
4
CH ClR = 0.998
CH CIF
3
2
- 2 01 1 2
«mol
b- Relationship Between Amount in Animal 
and Remaining in Atmosphere and OCMol
Figure 4.4 Relationship Between the Ratio of the Amount of 
Dihalomethanes in Animal/Concentration in Atmosphere and Log P and
a  Mol
93
4.3.3 TISSUE GLUTATHIONE DEPLETION
There were neither changes in the total glutathione content in the lungs (Figure 4.5) nor in 
the GSSG concentration in liver and lungs of rats exposed to different concentrations of 
dihalomethanes (data not shown). CH 2 CI2  and CH 2 FCI depleted the total glutathione o f the 
liver significantly at exposure concentrations above 2000 ppm (Table 4.3). There was no 
significant change in total glutathione content of liver of rats exposed to CH2 F 2 .
4 .3.4 SERUM  ENZYMES AND HISTOLOGY
None of the compounds altered either serum enzyme activities or the histological profiles of 
liver, lung and kidneys (data not shown) of rats exposed to different concentrations by 
inhalation.
4.3.5 SPECTRAL INTERACTION W ITH HEPATIC M ICROSOM AL FRACTION
The binding spectra of the three compounds with microsomal preparations from 
phenobarbitone-induced rats were studied. They all interacted with hepatic microsomal 
fraction giving a type I binding spectra, exhibiting peaks at 385-388nm and troughs at about 
420nm. Table 4.4 shows the spectral binding constants. Kg and AA^ax which were calculated 
from the analysis of the binding spectra. The Kg value of CH2 FCI was the lowest of the 
three compounds while the highest value was that of CH2 F 2 . AA^ax values were 
approximately the same for the three compounds.
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Figure 4.5 Total Glutathione Content in the Lungs 
after a Three Hour Exposure to Dihalomethanes
Each v a lu e  rep rese n ts  t h e  m ean  o f  3 or 4 rats ±  S . E . M .
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Table 4.4 CONSTANTS DERIVED FROM THE BINDING SPECTRA OF
DIHALOMETHANES
Compound K 3 (mM) ^■^max
C H .C l, 6 . 0 + 0 . 8 0 .0 3
CH ,FC 1 2 . 0 + 0 . 4 0 .0 4
C H .F , 1 1 . 1 + 0 . 6 0 .0 4
Each value is the m ean o f  three determ inations ±  S .E .M .
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When either CH 2 CI2  or CH 2 F 2  was added to sodium dithionite-reduced microsomal 
suspension, the type I difference spectra was not observed,but a small peak at about 445nm 
was recorded immediately which did not change with time. CH 2 FCI also yielded a reduced 
spectrum with sodium dithionite-reduced microsomes. The peak was larger than that 
produced by either CH 2 CI2  or CH 2 F 2  but also had its maximum at 445nm. None of the three 
compounds decreased the magnitude of the P450-CO peak in comparison to that of controls 
when CO was bubbled in the test cuvette at the end of the experiment. The wavelength 
maxima of the reduced spectra obtained with dihalomethanes are presented in Table 4.5. 
Under anaerobic conditions, CH2 CI2  interacted with NADPH-reduced microsomes giving a 
peak at 448nm and a trough at about 403nm. The peak was time-dependent and reached its 
maximum in 80min. The rate of formation of NADPH-reduced spectra in liver microsomes 
from rats treated with phenobarbitone under anaerobic conditions with CH2 CI2  is shown in 
Figure 4.6.
CH 2 FCI and CH 2 F 2  gave spectra with NADPH-reduced microsomes with broad peaks around 
415 to 420. The peak obtained with CH 2 FCI was time-dependent, and reached its maximum 
after one hour, whereas the peak formed with CH 2 F 2  reached its maximum after 5min and 
then started to disappear. Table 4.6 shows the spectral maxima in NADPH-reduced 
microsomal suspension of rats under anaerobic conditions with dihalomethanes.
None of the three compounds altered the magnitude of the P450-CO peak in comparison with 
controls when sodium dithionite and CO were added to the test cuvette at the end of the 
experiment. Upon addition of dihalomethanes to either sodium dithionite- or NADPH- 
reduced micromes the same peaks were recorded. No other peaks were noticed when Hb
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Table 4.5 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS OF
DIHALOMETHANES WITH SODIUM DITHIONITE-REDUCED 
RAT MICROSOMAL FRACTIONS
Compound Final Concentration (mM) Spectral Maximum (nm)
CU.CU 1 4 4 5 ,
C H T C l 2 4 4 5
C H T , 2 4 4 5 ,
1 . sm all peak
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Figure 4.6 Rate of Formation of NADPH- Reduced Spectra in Rat Microsmes with 
Dichloromethane under Anaerobic Conditions
1 0 0
Table 4.6 W AVELENGTH MAXIMA O F SPECTRAL INTERACTIONS 
O F DIHALOM ETHANES W ITH NADPH-REDUCED RAT 
M ICROSOM AL FRACTIONS UNDER ANAEROBIC 
CONDITIONS
Compound Final Concentration (mM) Spectral Maximum (nm)
C H .C L 1 4 4 8
C H ,FC 1 2 4 1 5  to  4 2 0
C H F , 2 4 1 7  to  4 2 0
1 0 1
was added to both cuvettes (results not shown).
DETECTION O F REACTIVE M ETABOLITES
No changes were recorded in reduced GSH values upon incubation of dihalomethanes with 
phenobarbitone-induced liver microsomes, NADPH generating system and GSH in the 
presence of oxygen at 37°C. The results were similar to control experiments in which the 
same mixture was incubated in absence of substrate. When the dihalomethanes were 
incubated with GSH in a similar way to the above experiment but under anaerobic conditions, 
GSH depletion occurred. This depletion decreased with increasing fluorine content (Table 
4.7). No depletion of GSH was noticed when the NADPH generating system was omitted 
(data not shown).
4.4 DISCUSSION
The results of this study demonstrate the close relationship which exists between uptake of 
dihalomethanes and their lipophilicity. Analysis of the uptake curves of CH 2 CI2  and CH 2 CIF 
shows that these had contributions from both first-order and saturable metabolic pathways. 
The data for CH 2 F 2  were consistent with a first-order uptake pathway and a minor metabolic 
component. In contrast to these findings, Gargas et al., (1986) reported a single first-
1 0 2
Table 4.7 GSH DEPLETION W ITH DIHALOM ETHANES UNDER
ANAEROBIC CONDITIONS
Compound GSH Depletion (nmol/mg protein/30min)
C ontrol 0
C H .C L  (lO m M ) 35  +  1 .6
C H .F C l (3 m M ) 16 +  1 .3
CH nF. (3 m M ) 0
V alues represent m eans +  S .E .M  o f  6  incubations w ith hepatic m icrosom es from  rats treated  
with phenobarbitone
Control =  incubation m ixture w ithout substrate. N o  lo ss o f  G SH  occurred in the control 
incubation
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order uptake pathway for CH 2 CIF whereas CH2 F 2  showed no evidence for either a high 
affinity saturable or first-order component. This disagreement may be due to the fact that 
these authors could not obtain CH2 CIF and CH 2 F 2  as pure gases. Lower concentrations (10, 
70, 170 ppm) of a mixture of 70% of CH2 CIF and 30% of CH 2 F 2  were used in their study. 
However, the findings obtained by these workers with CH2 CI2  were comparable with the 
results of the present investigation.
The study reported in this chapter also describes the linear relationship between the amount 
in animal and the concentration remaining in atmosphere after the end of exposure to 
dihalomethanes. The slope of the lines obtained decreased with increasing fluorine content 
possibly reflecting the dependence of uptake on lipophilicity. The existence of a positive 
correlation between logarithmic value of the ratio of amount of dihalomethanes in animal/the 
concentration remaining in the atmosphere, and log P and amol indicates a structure-activity 
relationship.
Although CH 2 CI2  is more lipophilic than CH 2 FCI as shown by log P and amol values, its 
affinity of binding to P450, as indicated by the value, was lower than CH 2 FCI. This 
could be attributed to the fact that different isoenzymes of P450 from those induced by 
phenobarbitone may be responsible for potentiation of CH2 CI2  binding and metabolism. 
Pankow and Hoffmann, (1989) speculated that the toxicodynamic effects of CH 2 CI2  could be 
influenced by treatments such as isoniazid, acetone or fasting which induce cytochrome 
P4502E1 (P450J).
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The depletion of hepatic GSH by CH 2 CI2  in vivo was not unexpected. Anders and co­
workers, (1977), proposed two pathways (1 and 2) for dihalomethanes, in which GSH is only 
an essential component of pathway 2 (Fig 4.7). Pathway 3, which is only significant when 
the intermediate XCHO is relatively stable, and was proposed by Gargas et al. (1986), and 
also requires glutathione.
CH 2 CIF also depleted GSH in a similar fashion to CH 2 CI2  which suggests that this compound 
may follow CH 2 CI2  in its metabolic pathways. However, Green (1983) reported that the 
metabolism of CH 2 CIF to CO was only one tenth of that of CH2 CI2  with Aroclor-induced rat 
microsomes. In contrast to the other dihalogenated methanes, CH 2 F 2  produced no effects on 
hepatic GSH although its uptake data showed evidence of a minor metabolic component. 
This finding suggests that GSH may have no role in the metabolism of this compound.
In contrast to the depletion of hepatic GSH in rats, dihalomethanes failed to decrease total 
lung GSH. The significance of this observation may be due to the lower activity of drug 
metabolizing enzymes in the lungs or the absence of the appropriate isoenzymes. The liver 
is the major site of metabolic activity for the dihalomethanes. Kirschman er al. (1986) 
reported that the only target organ noted in 90-day study of CH 2 CI2  toxicity for either rats
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or mice was the liver.
The results have also shown that the GSSG concentration in either liver or lung did not 
increase in all rats exposed to dihalomethanes at different concentrations. The lack of 
changes in this parameter suggests that stimulation of lipid peroxidation by these compounds 
was not likely.
In vitro aerobic incubations of dihalomethanes with GSH failed to produce any thiol 
depletion, although reactive metabolites have been shown to bind to GSH in vivo (Anders et 
al., 1977; Ahmed and Anders, 1978). This can be explained by the likely low levels of 
contaminating cytosolic GSH transferases activity present in the washed microsomal 
suspension and therefore pathway 2 (Figure 4.7) can not take place. Garle and Fry (1989) 
reported similar results with iproniazid and naphthalene.
In contrast, under anaerobic conditions, CH 2 CI2  and CH 2 FCI depleted GSH in incubations 
containing a NADPH-generating system. This depletion may be due to the formation of 
reactive metabolites which bind to GSH anaerobically. This effect was abolished by omission 
of cofactors reflecting the dependence of metabolism on cytochrome P450. These results 
coupled with the formation of binding spectra with reduced microsomes anaerobically may 
suggest a possible reductive metabolic pathway for CH 2 CI2  and CH 2 FCI. Figure 4.8 
represents a suggested reductive metabolic pathway for dihalomethanes. The following facts 
support the speculations outlined in Figure 4.8:
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Figure 4.8 Possible Scheme for the Reductive Metabolism, of Dihalogenomethanes
and Fe^ "^  represent the oxid ised  and reduced form s o f  P 4 5 0  respectively .
A  represents com p lex  g iv in g  type I spectrum  
B represents com plex  g iv in g  reduced spectrum
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The formation of the 445nm peaks upon addition of dihalomethanes to sodium dithionite- 
reduced microsomes could be due to the interaction of the metabolic intermediate, carbene 
G (iCHj) with reduced cytochrome P450, and formation of complexes by analogy to that 
formed with CCI4. The hydrolysis of product G to methanol (CH3OH) would explain the 
inability to detect carbene formation by trapping CO with haemoglobin. However, CH 2 F 2  
also gave a 445nm complex with reduced microsomes and as this can not undergo reductive 
metabolism, due to its strong C-F bonds, the peaks at 445nm could be due, possibly, to the 
formation of complex B.
Complexes C and D (radical CH 2X) must be very transient and easily reduced to anion E 
(CH2 X). This prediction is based upon the fact that cytochrome P450 was not destroyed by 
the dihalomethanes as measured by the absence of a decrease in the magnitude of P450-CO 
peaks at the end of the incubation.
Formation of product F (CH3X) from complex B (CH2X) could account for GSH depletion 
by CH 2 CI2  and CH 2 CIF. This suggests that this proposed reductive process might operate 
for CH2CI2 and CH2CIF, to produce CH3CI and CH3F respectively, but can not take place 
with CH 2 F 2  even though it forms a complex with reduced cytochrome P450.
No changes in serum enzyme activities were seen in any of the rats exposed to 
dihalomethane. The histopathological evaluation of tissues revealed no compound-related 
effects. Similar findings were reported by Leuschner et al. (1984) when rats and dogs were 
exposed by inhalation to CH 2 CI2 . However, a recent National Toxicology Programme (NTP,
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1986) lifetime bioassay of CH 2 CI2  has shown an increased incidence of lung and liver 
tumours in B3 C3 F 1 mice but not F344 rats.
From all these, and in view of the low order of toxicity and limited metabolism of CH2 F 2 , 
it would appear that replacement of chlorine by fluorine results in less metabolism and 
possibility of reduced toxicity.
1 1 0
CHAPTER 5
SOME METABOLIC CHARACTERISTICS OF INHALED
TRIHALOMETHANES
1 1 1
5.1 INTRODUCTION
Chloroform CHCI3 is used widely as an industrial solvent and chemical intermediate. The 
mechanism of CHCl^-induced hepatotoxicity has received a great deal of attention over the 
past years. Pohl (1979) suggested that a reactive metabolite of CHCI3 is responsible for its 
hepatotoxicity and possibly its carcinogenicity and renal toxicity. The finding that CHCI3 
administration significantly decreased the level of liver GSH in rats pretreated with 
phenobarbitone further suggested that a reactive metabolite was produced (Brown et al., 
1974; Docks and Krishna, 1976).
When CHCI3 was incubated aerobically with rat liver microsomes from rats treated with 
phenobarbitone, NADPH generating system and G SH , diglutathionyl dithiocarbonate 
(GSCOSG ) was generated (Pohl et al., 1981). Phosgene (C O C y  was identified as a 
metabolite when CHCI3 was incubated with rat liver microsomes (Bhooshan et al., 1977; 
Pohl et al., 1977; Mansuy et al., 1977) and in rats (Pohl et al., 1979). The formation of 
COCI2  is 0 2 -dependent and appears to be catalysed by a phenobarbitone-inducible form of 
P450 (Pohl and Krishna, 1978; Sipes et ah, 1977; Uehleke and Werner, 1975). Pohl et al., 
(1980) indicated that phosgene is the major reactive metabolite of CHCI3 in rat liver 
microsomes and it appears to be formed by an initial direct insertion of activated O2 . Under 
anaerobic and reducing conditions CHCI3 forms a complex with cytochrome P450 with a 
Soret absorption band at 464nm which formed slowly (Wolf et al., 1977).
The replacement of chlorine in the CHCI3 molecule by fluorine may lead to changes in 
metabolism and toxicity. Dichlorofluoromethane (CHCI2F), chlorodifluoromethane (CHCIF2)
1 1 2
and trifluoromethane (CHF3) are known fluorinated analogues of CHCI3. Trochimowicz et 
al. (1977), have shown that CHCI2 F is metabolized to some extent in rats and dogs probably 
by cytochrome P450-dependent pathway. These workers identified fluoride as a metabolite. 
There is no reported metabolism of the other fluorinated analogues of CHCI3.
This chapter reports a study of the uptake, metabolic and toxicological implications of CHCI3 
and its fluorinated analogues CHCI2F, CHCIF2 and CHF3.
5.2 M A T E R IA L S  A N D  M E T H O D S
The details of animals and materials used were given in Chapter 2, Section 2.3. Inhalation 
exposures were conducted in a closed atmosphere exposure system as described in Chapter 
2, Section 2.3.
5 .2.1 M A T E R IA L S
CHCI3 was obtained from May and Baker Ltd., Dagenham, England. CHCI2F, CHCIF2 and 
CHF3 were purchased from Fluorochem Ltd., Old Glossop, Derbyshire, U .K. CHCI2F, 
CHCIF2 and CHF3 are gases at room temperature and therefore they were sampled by filling 
gas sample bags (SKC Inc, PA, 15330, USA) and the required aliquots were removed using 
a gas-tight syringe.
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5.2.2 DOSING
At least 6  rats were used for each concentration of chemical. Details of the concentrations 
used for each compound are given in Table 5.1.
5.2.3 SAMPLING 
TISSUE GLUTATHIONE
Rats were anaesthetized and liver and lungs were collected 2h after the end of exposure and 
analyzed for GSH and GSSG concentration according to the method described in Chapter 2, 
Sections 2.11.1 and 2.11.2 respectively.
5.2.4 ENZYM E ACTIVITIES
Blood was collected from anaesthetized rats 2 and 24h post-exposure and the serum was 
separated and stored at -80°C until analysis for sorbitol dehydrogenase (SDH), glutamate 
dehydrogenase (GDH) and lactate dehydrogenase (LDH) according to standard methods 
described in Chapter 2, Section 2.11.4.
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5.2.5 HISTOLOGY
Pieces of liver, lung and kidney were fixed in 10 per cent formol saline and paraffin sections 
6fim thick were cut and stained with haematoxylin and eosin (H & E) as described in Chapter 
2, Section 2.12.
5.2.6 BINDING SPECTRA
These were recorded between 350nm and 460nm using a microsomal suspension from rats 
pretreated with phenobarbitone. After a base-line was recorded, the substrate was added to 
the test while methanol was added to the reference cuvette. In the case of gases only the 
substrate was added to the test cuvette. The spectral binding constant (KJ was determined 
from absorbance changes over a range of different substrate concentrations. The absorbance 
change was taken to be the sum of the absorbance difference between the peak and base line 
and the base line and trough. Details of the method used were given in Chapter 2, Section 
2.9.1.
REDUCED SPECTRA
Reduced difference spectra were determined under reducing conditions either with sodium 
dithionite or NADPH under anaerobic conditions using microsomes from rats pretreated with 
phenobarbitone. These spectra were recorded between 390-500nm as described in Chapter 
2, Section 2.9.2. The possibility of CO formation during reduced microsomal incubation
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with the trihalomethanes was investigated by inclusion of haemoglobin in the incubations as 
described in Chapter 2, Section 2.10.
5.2.7 DETECTION OF REACTIVE METABOLITES
The ability of the trihalomethanes to deplete GSH in liver microsomal incubations as a result 
of reactive metabolites formation by the microsomal mono-oxygenase system was studied. 
Trihalomethanes were incubated with liver microsomes from rats pretreated with 
phenobarbitone, NADPH generating system and GSH under either aerobic or anaerobic 
conditions as described in Chapter 2, Section 2.11.3.
5.3 RESULTS
5.3.1 PHYSICO-CHEMICAL PROPERTIES OF TRIHALOMETHANES
The values of calculated log P and amol are highest with CHCI3, reflecting its high 
lipophilicity compared to its fluorinated analogues. Both parameters decreased gradually with 
increasing fluorine content (Table 5.2). AE was inversely correlated with chlorine content 
of the compound. The value of AE was highest with CHF3 reflecting its requirement for 
more energy to promote an electron from its highest occupied energy level to its lowest 
unoccupied energy level.
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Table 5.2 PHYSICO-CHEMICAL PROPERTIES OF TRIHALOMETHANES
Chemical am ol (Â^) AE (eV) log P 
(calculated)
C H C I3 4 .8 5 1 4 .8 1 .9 5 2
C H C h F 4 .0 7 1 5 .2 1 .5 1 2
C H C IF . 3 .1 8 1 6 .7 1 .0 7 2
C H F 3 2 .6 1 2 2 .7 0 .6 3 2
AE d ifference b etw een  E(H O M O ) and E (L E M O ) 
H O M O  highest occupied  m olecular orbital 
LE M O  low est em pty m olecular orbital
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5.3.2 THE UPTAKE OF TRfflALOMETHANES
The uptake curve for CHCI3  was characterized by an initial rapid phase (50min) followed by 
an essentially first-order phase. The magnitude of the initial phase declined markedly with 
increasing fluorine content (Figure 5.1). Analysis of the first-order phase for CHCI3  showed 
that it displayed a complex uptake behaviour with contributions from both a first-order uptake 
component and a saturable component (presumed to be metabolism) with an abrupt first- to 
zero-order transition (Figure 5.2 A).
The data for CHCI2F was suggestive of a significant metabolic component but this compound 
produced some peculiar curves above SOOOppm. For this compound (Figure 5.2 B), the point 
of inflexion corresponded to a concentration of about SOOOppm.
There was a lower affinity saturable component and a first-order component for GHCIF2 . 
In contrast, the behaviour of the uptake of CHF3  was consistent solely with a first-order 
process. Considering the data of Figure 5.1 at the 3 hour time points only, there was a 
linear relationship between the amount of compound in the animal and the initial atmospheric 
concentration of trihalomethanes and the slope of lines were almost identical for CHCI3  and 
CHCI2 F and decreased with increased fluorine content (Figure 5.3). However, the greatest 
reduction in slope of the lines of the group was shown by CHCIF2 .
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5.3.3 BINDING SPECTRA OF TRIHALOMETHANES
The binding spectra of four trihalomethanes; CHCI3, CHCI2F, CHCIF2, CHF3, with 
microsomal preparations from phenobarbitone-pretreated rats were all of the type I category 
representing the formation of an enzyme-substrate complex, exhibiting peaks at about 385- 
388nm and troughs at about 420nm.
Table 5.3 shows the spectral binding constants (KJ of the trihalomethanes. Considering the 
first three trihalomethanes in Table 5.3, the binding affinity for hepatic P450 (KJ was 
greatest with CHCI3  representing its high lipophilicity as measured by log P value. IQ value 
for CHF 3  was even lower than CHCI3 which suggests a higher affinity to P450 than CHCI3 . 
However, CHF 3  has the lowest log P value of the group. AA^ax decreased in magnitude with 
increasing fluorine content.
When microsomal suspensions from rats pretreated with phenobarbitone were reduced with 
sodium dithionite and CHCI3 was added to the test cuvette, a type I difference spectrum was 
not observed but a small peak at 420nm and a relatively bigger one at 465nm were recorded. 
The peak at 420nm disappeared within the first 5 min while the peak at 465nm started to 
increase. The formation of the spectrum was time-dependent and the time required to 
achieve its maximal interaction was in excess of 30 min (Figure 5.4). The magnitude of the 
interaction was dependent upon substrate concentration.
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Table 5.3 CONSTANTS DERIVED FROM THE BINDING SPECTRA OF 
TRIHALOMETHANES
Chemical K, (mM) AA^gx
CHCI3 2.27 +  0.2 0.08
CHChF 12.0+0.5 0.08
CHCIF, 3 .57+ 0 .3 0.04
CHF3 0 .67+ 0 .07 0 . 0 1
Each value represents the mean of 4 experiments ±  S.E.M.
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Figure 5.4 Rate of Formation of Sodium Dithionite- Reduced Spectra in Rat 
Microsomes with Chloroform
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CHCI2F, CHCIF2, and CHF3 interacted with sodium dithionite-reduced microsomes giving 
peaks at about 445nm (Table 5.4). The magnitude of the peaks with CHCI2F and CHF3 were 
similar to CHCI3 maximum spectra whereas the CHF2CI peak was smaller. The rate of 
formation of these peaks was not time dependent.
When CO was bubbled in the test cuvette containing CHCI3 at the end of the experiment, the 
magnitude of P450-CO peak was found to be decreased by about 22% compared to the 
control experiment without CHCI3. No decrease in the P450-CO peak was found with the 
fluorinated analogues of CHCI3.
Upon reduction with NADPH of anaerobic liver microsomes from rats pretreated with 
phenobarbitone, and addition of CHCI3 to the test cuvette, a peak at 466nm started to develop 
within 5 min. After this time, there was a spectral shift to 453nm within the next 45 min. 
Similar to the experiment with sodium dithionite-reduced microsomes, the formation of the 
peak was time-dependent. The rate of formation of the spectrum with NADPH-reduced 
microsomes and CHCI3 under anaerobic conditions was linear up to 1 hour (Figure 5.5).
With the fluorinated analogues of the group, a peak at about 414-418nm was formed 
immediately after the addition of the compound and disappeared after about 7 min (Table 
5.5).
At the end of the experiment with CHCI3 , when sodium dithionite was added to the reference 
and test cuvettes and CO was bubbled into the test cuvette, the P450-CO peak was decreased
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Table 5.4 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS OF 
TRIHALOMETHANES WITH DITHIONITE-REDUCED RAT 
MICROSOMAL SUSPENSIONS
Chemical Final Concentration (mM) Spectral Maxima (nm)
CHCI3 1 , 2  and 4 4 2 0  (sm a ll) , 4 6 5
CHChF 2 4 4 5
CHCIF. 2 4 4 5
CHF3 2 4 4 5
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0 . 0 2 -
0.00
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Figure 5 S  Rate of formation of NADPH-Reduced Spectra under Anaerobic 
Conditions with Chloroform
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Table 5.5 W AVELENGTH MAXIMA O F SPECTRAL INTERACTIONS 
O F TRIHALOM ETHANES W ITH NADPH-REDUCED RAT 
M ICROSOM AL SUSPENSIONS UNDER ANAEROBIC 
CONDITIONS
Chemical Final Concentration 
(mM)
Spectral M axima 
(nm)
CHCI3 1 466, 453
CHChF 2 414
CHCIF2 2 416
CHF3 2 418
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by 23% compared to a control experiment in the absence of substrate.
No alteration in P450-CO peak was recorded with the fluorinated compounds of the group 
and the results were similar to control experiments.
When CHCI3 was added to sodium dithionite-reduced microsomes, the maximum spectrum 
was produced at about 465nm after 25 min as before. On the addition of haemoglobin to 
both test and reference cuvette in equal amounts, two peaks were recorded; one at 465nm 
and a small peak at 418nm which was a typical haemoglobin-CO difference spectrum. The 
same results were obtained with CHCI2F but not with CHCIF2 or CHF3 (Table 5.6).
When the same experiment was repeated with NADPH-reduced microsomes and CHCI3 , no 
CO-Hb spectrum was obtained. With CHCI2 F, CHCIF2  and CHF3 , the experiments with 
NADPH-reduced microsomes under anaerobic conditions were not done, because the spectra 
formed with these compounds were at about 418nm as shown previously (Table 5.6).
5.3.4 TISSUE GLUTATHIONE
There was no significant depletion of total glutathione in the lungs of all rats exposed to 
different concentrations of the trihalomethanes. GSSG concentration did not increase and
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Table 5.6 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS 
OF TRIHALOMETHANES WITH MICROSOMES REDUCED 
EITHER WITH SODIUM DITHIONITE OR NADPH UNDER 
ANAEROBIC CONDITIONS IN THE PRESENCE OF 
HAEMOGLOBIN
Wavelength Maxima (nm)
Chemical Sodium 
dithionite +  Hb
NADPH +  Hb 
anaerobically
C H C I3  (Im M ) 4 1 8 *  and 4 6 5 4 5 3
C H C I3F  (2 m M ) 4 1 8 +  and 4 4 5 nd
C H C IF , (2 m M ) 4 4 5 nd
C H F 3  (2 m M ) 4 4 4 nd
* Sm all peak
+  V ery sm all peak
nd N ot done because the com pounds them selves g ave  peaks at 418nm  w h en  added to N A D P H -
reduced m icrosom es
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the values obtained were similar to control rats (data not shown).
Table 5.7 shows the total glutathione content in rat liver after 3 hour initial exposure by 
inhalation to the trihalomethanes. Total hepatic glutathione decreased significantly at 
concentration of 4000ppm with CHCI3. No significant changes were observed in total 
glutathione in liver of rats exposed to CHCI2 F and CHCIF2  at all concentrations used. 
However, there was a significant decrease in total hepatic glutathione of rats exposed to 
CHF3 at a dose of 3000ppm, and the effect observed provided evidence of being dose-related.
5.3.5 DETECTION O F REACTIVE M ETABOLITES
On aerobic incubation of CHCI3 with liver microsomes from rats pretreated with 
phenobarbitone, NADPH generating system and reduced GSH, there was depletion of GSH 
up to 41nmol/mg protein/30min compared to control experiments under the same conditions, 
in absence of the substrate. No depletion was produced with other compounds of the group 
(Table 5.8).
Under anaerobic conditions CHCI3 depleted reduced GSH to almost double the amount (about 
70nmol/mg protein/30min) of that when incubated aerobically (Table 5.9). The depletion 
of GSH decreased with increasing fluorine content with the exception of CHCIF2  where 
almost no depletion occurred and the value obtained was near to control experiment. The 
depletion of GSH mediated by these compounds, aerobically or anaerobically.
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Table 5.8 GSH DEPLETION IN RAT LIVER MICROSOMES UNDER
AEROBIC INCUBATION WITH TRIHALOMETHANES
Compound Concentration
(mM)
GSH depletion* 
(nmol/mg protein/30min)
C H C I3 1 0 4 1 ± 1 . 4
C H C h F 3 0
C H C IF . 3 0
C H F 3 3 0
* R esu lts w ere corrected for the depletion  o f  G SH  that occurred in the control incubation w hich  
less than 13% (range 9-15% , n = 6 )
Each value represents the m ean o f  6  incubations ± S .E .M .
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Table 5.9 GSH DEPLETION IN RAT LIVER MICROSOMES UNDER
ANAEROBIC INCUBATION WITH TRIHALOMETHANES
Chemical GSH depletion (nmol/mg protein/30 min)
contro l 0*
CHCI3 (lO m M ) 7 0 ± 2
CHChF (3 m M ) 31 +  1 .6
CHCIF2  (3 m M ) 4 + 0 . 5
CHF3 (3 m M ) 15 +  1 .5
Each value represents the m ean o f  6  incubations ± S .E .M  
Control =  incubation in the absence o f  substrate 
*  no loss o f  G SH  occurred in the controlincubation
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was abolished by omission of cofactors.
SERUM  ENZYM E ACTIVITIES
There were no significant changes in the activities of sorbitol dehydrogenase and lactate 
dehydrogenase in sera of rats either 2 or 24 hours after a 3 hour exposure to different 
concentrations of CHCI3 , CHCIF2  and CHF3 . However, either 2 or 24 hours after the end 
of the exposure to CHCI2 F, the activity of SDH in sera of rats was significantly higher than 
that of control rats (Tables 5.10 and 5.11). For each initial concentration with this 
compound, a variable number of results were obtained due to the difficulty in producing the 
same initial concentration.
Figure 5.6 shows that there was a positive correlation between SDH activity in sera of rats 
exposed to CHCI2 F 2  hours after the end of exposure and the initial atmospheric 
concentration (r =  0.74, P <  0.05).
No linear relationship was found between SDH activity of sera from rats collected 24h post­
exposure to CHCI2 F and its initial atmospheric concentration. No significant changes were 
observed with either LDH or GDH activities in sera (data not shown).
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Table 5.10 SORBITOL DEHYDROGENASE ACTIVITY IN SERA OF RATS 2 
HOURS AFTER EXPOSURE TO DIFFERENT ATMOSPHERIC 
CONCENTRATIONS OF CHCl^F FOR 3 HOURS
Initial concentration (ppm) SDH Activity (U/1)
control 1 .0  +  0 .5  ( n = 6 )
5 0 0 1 .4  ( n = l )
2 2 0 0  ±  171 3 .6  ±  2 .6  ( n = 3 )
3 4 0 0 7 .3 ,  8 .3  ( n = 2 )
5 1 0 0 9 .0  ( n = l )
V alues are the m ean o f  n rats ±  S .E .M  or values for individual anim als
Sam pling tim e w as 2h after end o f  experim ent. N um ber o f  anim als used for each concentration  w as  
sm all due to the d ifficu lty  in producing the sam e initial concentration each tim e.
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Table 5.11 SORBITOL DEHYDROGENASE ACTIVITY IN SERA OF
RATS 24 HOURS AFTER EXPOSURE TO DIFFERENT 
CONCENTRATIONS OF CHCl^F
Initial Concentration (ppm) SDH Activity (U/1)
contro l 0 .8  ±  0 .4 8  ( n = 7 )
1 0 0 0 2 .0 5 8  ( n = l )
1 4 0 0  ±  130 3 .0  ±  0 .8  ( n = 3 )
2 0 0 0 4 .5  ±  2 .9 5  ( n = 3 )
2 6 0 0  ±  143 6 .4  + 3 . 7  ( n = 3 )
3 6 0 0 1 1 .0 , 3 .9  ( n = 2 )
4 8 0 0 8 .2  ±  5  ( n = 3 )
V alues are the m ean o f  n rats +  S .E .M , or values for individual anim als.
Sam pling tim e w as 24h after end o f  experim ent. N um ber o f  anim als used for each  concentration  w as  
sm all due to the d ifficu lty  in producing the sam e concentration each tim e.
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10 -1
0  1 0 0 0  2 0 0 0  3 0 0 0  4 0 0 0  5 0 0 0  6 0 0 0
(ppm )
Initial atmospheric concentration
Figure 5.6 Relationship Between SDH Activity in Sera 2 Hours after 
Exposure and Initial Atmospheric Concentration of Dichlorofluoromethane
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Compared to control animals, no histopathological changes which could be related to the 
compounds were observed in lungs, liver and kidneys of rats exposed by inhalation to 
different concentrations of CHCI3, CHCIF2 and CHF3, (data not shown).
Rats exposed by inhalation to 2000ppm, or above, of CHCI2 F showed hepatic changes 
histologically. There were some necrotic hepatocytes in the centrilobular zone of the liver 
and mononuclear leucocytic infiltration (Figure 5.7). The centrilobular hepatocytes had 
homogenous eosinophilic appearance due to cytoplasmic degenerative changes (Figure 5.8). 
The lungs and the kidneys were similar to those of the control.
5.4 D IS C U S S IO N
It is clear from the results that the affinity of the metabolizing enzymes for CHCI3  is high. 
The shape of the rate of uptake curve fell well within the various curves of various values 
of the ratio obtained by Andersen (1981) who studied the kinetics of metabolism of
inhaled gases (G.Loizou, personal communication). The marked uptake (Figure 5.3) and 
metabolism (Figure 5.2 A) of CHCI3  correspond with its higher lipophilicity and tissue 
solubility compared to its fluorinated analogues.
The data for CHCI2 F suggest a significant metabolic rate, however, there was a sudden and 
surprising peculiar downturn of the curve at about 4000ppm. This may suggest that
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Figure 5.7
Liver of control rat (centrilobular zone) H & E x 250.
3  e .%
»
Some hepatocellular necrosis and leucocytic infiltration on the central vein region of 
liver of rat No 128 exposed to 3500 ppm of CHCI2 F by inhalation x 250.
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Figure 5.8
m a
y .  m  à  .
' ù
Liver of control rat. Centrilobular region and portal area x 100.
« « l a a
Eosinophilic stained centrilobular area of rat liver exposed to 4700ppm of CHCI2 F by 
inhalation x 1 0 0 .
142
the rate-limiting factor could be the respiration rate. Because of the anaesthetic effect of this 
compound, the respiration rate of rats may decrease rapidly soon after exposure with a 
consequent decrease in the uptake of the vapour at about 3000ppm. A longer exposure time, 
above 3h with recovery from the anaesthetic effect might have resulted in a linear uptake 
component similar to that seen at the 3000ppm exposure.
Comparing the curves obtained by Andersen (1981) with the present rate of uptake curve of 
CHCIF2 , suggests that the affinity of the metabolizing enzymes for this compound is low in 
relation to the maximum capacity for hepatic metabolism. Similar findings were obtained 
by Peter et al. (1986) who compared the pharmacokinetics of CHCI2 F and CHCIF2 . These 
workers found that CHCI2 F was readily eliminated via metabolism while CHCIF2  underwent 
no detectable metabolism.
CHF 3  has only a first-order uptake component which may be due to its lower lipophilicity 
as reflected by its log P value, compared to the other compounds of the group. However, 
surprisingly CHF3 has the highest affinity of binding to P450 in this group, but this might 
not be related to its metabolism, as Chaplin and Mannering (1970) suggested that spectral 
interaction was not a pre-requisite for metabolism, as phospholipase C digestion abolished 
the type I spectra but did not prevent metabolism of a type I substrate.
The results of this study indicate that all the trihalomethanes are lipophilic and are able to 
interact with the active site of liver microsomal P450 (Table 5.3). However, the extent of 
interaction, as given by AA^ j^ x varied depending on the chlorine content. This could be seen 
from the formation of the high-spin enzyme substrate complex. Similar results were obtained
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by Cox et al. (1976) when they studied the binding of tetrahalomethanes with cytochrome 
P450. These authors proved that the binding site was within the phospholipid portion of the 
cytochrome P450-complex by the abolition of the type I spectrum after iso-octane extraction 
of the microsomal fraction. Unlike the trihaloethane series (Chapter 3) or the 
tetrahalomethanes (Chapter 6 ), there was no simple relationship between K, values and c log 
P, and the order of decreasing affinity was CHF3 >  CHCI3 >  CHCIF2 >  CHCI2F. This 
could indicate that this series of compounds interacts with different isoenzymes of P450 or 
orientate differently within the active site of the enzyme.
In animal experiments, CHCI3 significantly depleted total G SH  at a concentration of 
4000ppm. This result was in agreement with previous observations reported by Pohl et al. 
(1980; 1981) in which GSCOSG has been identified as a metabolite of CHCI3 metabolism. 
Brown et al. (1974) have also reported that glutathione depletion due to CHCI3 increased 
significantly upon induction of microsomal enzymes with phenobarbitone. These results were 
supported by the effective depletion of reduced GSH by CHCI3 in in vitro experiments on 
incubation aerobically with reduced GSH, a NADPH generating system and microsomes 
from rats treated with phenobarbitone. These findings coupled with the marked uptake and 
metabolism (Figure 5.2 A) of CHCI3 were in agreement with the suggested oxidative pathway 
reported by Pohl et al. (1980) (Figure 5.9).
In this pathway, phosgene (COCI2 ) could account for glutathione depletion in vivo and in in 
vitro experiments.
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In the presence of O2 , and in view of the similarities in uptake and metabolism to CHCI3 , 
CHCI2 F ' ; may follow the same scheme of reaction (Figure 5.10) as CHCI3  with the
formation of COCIF which accounts for binding to tissue molecules and toxicity. However, 
neither depletion of total glutathione nor reduced GSH was observed in vivo or in in vitro 
experiments respectively with CHCI2 F. These findings suggest that the reaction of COCIF 
may proceed more towards binding to tissue molecules and toxicity (Figure 5.7 and 5.8) 
rather than conjugation with glutathione.
In the present experiments, the lower uptake of CHCIF2  (Figure 5.3) compared to the other 
members of the series and its limited metabolism (Figure 5.2 C) were consistent with absence 
of glutathione depletion either in vivo or in in vitro experiments.
There was no evidence of oxidative metabolism for CHF3  (Figure 5.2 D) and its uptake was 
lower than CHCI3 and CHCI2 F. However, depletion of glutathione in vivo occurred with 
this compound which was concentration-dependent. The formation of COF 2  in a manner 
similar to the production of COCI2  from CHCI3  or COCIF from CHCI2 F (Figures 5.9 and 
5.10) seems to be unlikely. This fact is based on the difficulty of cleavage of C-F bonds. 
However, COF2  was formed chemically by spontaneous dehydrofluorination at temperatures 
above -20°C of the unstable CF3 OH (trifluoromethanol), the only trihalomethanol derivative 
that has been synthesized (Kloter and Seppelt, 1979; Seppelt, 1977).
The results have shown that upon reduction of microsomes with sodium dithionite, all the 
trihalomethanes produced difference spectra with Soret bands between 445-465nm. It is
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H OH
P450, Oj
Cl -  c  -  Cl C l -  c -  Cl
Cl Cl
2HC1 + CO.
O
Cl -  C -  Cl
;gsh O
 > GS-C-SG
- 2 cr
BINDING TO TISSUE 
MOLECULES AND TOXICITY
Figure 5.9 Metabolic Pathway of Chloroform in the Presence of O2
from Pohl et al. (1980).
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H OH
C l -  C -  F
P450, O 2
C l -  C -  F
Cl Cl
H C l +  C O . +  H F Cl -
O
II
C -  F
BINDING TO TISSUE 
MOLECULES AND TOXICITY
Figure 5.10 Proposed Pathway of CHCI2 F Metabolism in The Presence of Oj
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likely that the Soret band at 465nm obtained with CHCI3  was due to the formation of a 
carbene-cytochrome P450 complex. Such spectral peaks have been observed for several 
halogenomethanes, including CCI4  (Wolf et al., 1977; Ullrich and Schnable, 1973), CCI3F 
(W olf et al., 1977; Cox et a l ,  1976; W olf e ra /., 1975) and CHCI3  (W olf et a l ,  1977). The 
decreased content of P450 observed after incubation with CHCI3  may be related to radical 
formation prior to the formation of the carbene complex by CHCI3 . This result confirmed 
previous findings reported by Brown et al. (1974) and Fiorucci et al. (1988). As CO is a 
known hydrolysis product of dihalogenocarbenes (Hine, 1950; Hine and Dowell, 1954) the 
time-dependent formation of difference spectra with CHCI3  could be explained by the 
formation of the cytochrome P450 complex with CO. When difference spectra were taken 
in the presence of Hb to trap CO, only CHCI3  and CHCI2 F gave clear evidence of CO- 
formation. Similar findings were observed by Ullrich et al. (1978) on CO-formation 
obtained in the interaction of various halogenomethanes with ferrous cytochrome P450. This 
may suggest that CHCI3 and CHCI2 F have a similar reaction scheme when reductively 
metabolized.
With NADPH-reduced liver microsomes from rats pretreated with phenobarbitone, the 
formation of carbenes with CHCI3 and CHCI2F was also possible although 
carboxyhaemoglobin was not detected. An explanation for that could be that CO may be 
formed in traces beyond the limits of detection. That no CO was formed in the case of 
CHCIF2 and CHF3 with sodium dithionite-reduced microsomes could be attributed to the 
absence of formation of carbene complexes with these compounds.
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The results have shown that under anaerobic conditions all the trihalomethanes, with the 
possible exception of CHCIF2, produced depletion of reduced GSH in vitro when incubated 
with microsomes, NADPH generating system and reduced GSH. This could be explained 
by the fact that at low concentration of O2 , the haloalkanes can compete effectively for the 
electrons of cytochrome P450 with the formation of carbene or reactive free radicals 
(Nastainczyk et al., 1977). That could be the case with CHCI2 F where a decrease in 
respiration rate due to an anaesthetic effect was suspected. With CHCI3 under anaerobic 
conditions, the magnitude of GSH depletion increased to almost double. This provides 
evidence that CHCI3 may be metabolized more anaerobically with the formation of highly 
reactive intermediates possibly CHCI2 or a carbene (:C H C 1). The depletion of GSH observed 
was abolished by omission of cofactors. This is further evidence for the involvement of 
cytochrome P450. Figure 5.11 shows a speculative reductive metabolic pathway for 
trihalomethanes.
The formation of the 465-466nm peaks on addition of CHCI3  to sodium dithionite-reduced 
microsomes could be due to the interaction of the reactive intermediate :CHC1 with reduced 
microsomes and formation of complex F (:CHX-Fe?+). Complex B and D could account for 
the formation of the reduced spectrum at 414-418nm and 444-445nm with NADPH and 
sodium dithionite-reduced microsomes respectively with CHCI2 F, CHCIF2  and CHF 3 . The 
free radical complex E ( CHX 2 -Fe^+) which may be formed by dehalogenation of transient 
intermediate C could explain the destruction of P450 observed with CHCI3 . Carbenes usually 
interact with nucleophiles such as H 2 O or GSH as follows:
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:CHX + HjO
HO H
X
H X
HX + HCHO
:CHX + GSH
/ GS HA GSHT GS-CH.-SG
X
This could account for the high reduced GSH depletion observed with CHCI3 under anaerobic 
conditions and possibly also that seen with CHCI2 F.
These postulated reactions, however, do not account for the formation of CO  which is seen 
with CHCI3 and CHCI2F. By analogy with the formation of CO  from CH2CI2, the likely 
source of CO formation is by hydrolysis of the haloform to dihalogenomethanol intermediate 
as follows:
X X
\ /
/ \  
H X
HjO HX
HO X 
\  / HXy  ,
0 X 
c
/  \  
H X
1
H
CO + HX
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Fe^+ c Fe^+ Fe^+ c Fe"+
C H X 3 C H X 3 [ C H X 3 ] " [ C H X 3 ] -
B D
\
F e ^ + F e ^ + 2 e- F e ^ +
: C H X C H X 2 C H X z
Figure 5.11 P o s s ib le  Schem e for  the  R e d u c t iv e  M e t a b o l i s m  of  
Trihalogenomethanes
and Fe^  ^ represent the oxidised and reduced forms of P450 respectively. 
A represents complex giving type I spectrum 
B represents complex giving reduced spectrum with NADPH 
D represents complex giving reduced spectrum with sodium dithionite
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It is possible that this hydrolytic reaction is supported by cytochrome P450 (or some other 
component of the microsomes) and is favoured by reducing conditions. Since this reaction 
occurred primarily under the strong reducing conditions with dithionite, complex D [(CHXj)'— 
Fe '^*'] might be involved.
These proposals do not directly account for the surprising finding that CHF3 depleted total 
GSH in vivo but only under reducing conditions in vitro. This suggests that CHF3 may be 
metabolised reductively in vivo. In vitro, CHF3 behaved like CHCI2 F in all respects other 
than the production of CO in the presence of sodium dithionite. This suggests that hydrolysis 
to the difluoromethanol intermediate does not occur, a reaction which would require cleavage 
of the strong C -F  bond. For similar reasons, it is unlikely that the carbene :C H F  is formed, 
and there is also no spectral evidence for this. Despite this, it seems more likely that the 
active nucleophile of glutathione, GS'displaces a fluoride ion rather than the hydrogen atom 
and it is possible that the defluorination reaction is favoured in close proximity to the reduced 
haem centre in complex B (CHX3 -Fe^'^) to give the reaction
C H F 3  +  G S '   >  G S - C H F .  +  F -
It would be interesting to see if there was evidence for this reaction, both in vitro and in 
vivo.
There were neither changes in serum enzyme activities nor histopathologically in liver, 
kidney and lungs of rats exposed by inhalation to CHCI3. These results were in agreement 
with previous reports that CHCI3 biotransformation was increased in animals pretreated with
152
phenobarbitone (Brown et al., 1974). Untreated animals exposed to CHCI3  do not have 
pronounced hepatotoxicity because of the low generation of COCI2  or free radicals (CHCI2 ) 
which permits the liver to maintain an adequate supply of GSH. Illelt ef al. (1973) reported 
similar findings with CHCl3 -induced centrilobular necrosis in mice pretreated with 
phenobarbitone.
In the present experiments inhaled CHCI2 F produced hepatotoxic effects evidenced by 
centrilobular necrosis and cellular inflammatory infiltrations. Weigand (1971) and 
Trochimowicz et al. (1977) reported severe lesions of the liver parenchyma in laboratory 
animals, similar to those induced by CHCI3, after long exposure to CHCI2F. The 
hepatotoxic effect of CHCI2 F could be attributed to the formation of highly reactive free 
radicals such as CH C IF or carbene which may be formed under low concentration of O2  
(Nastaincyzk et al. , 1977). The damage to the liver is consistent with the increase in activity 
of SDH in the sera of rats. The importance of SDH in short-term inhalation test for 
evaluating industrial heptotoxicants has been previously discussed (Brondeau et al., 1983). 
It seems reasonable therefore, to conclude that the fluorinated analogues of CHCI3 may also 
be metabolized especially reductively but to a lower extent compared to CHCI3 and their use 
in industry may be questionable.
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CHAPTER 6
STUDIES ON THE METABOLIC EFFECTS OF INHALED 
TETRAHALOMETHANES
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6.1 INTRODUCTION
Carbon tetrachloride (CCI4) has been extensively studied in the past years (Recknagel, 1967; 
Recknagel and Glende, 1973, 1988; Recknagel e ta L , 1977; Brattin etal] 1985; Slater, 1972 
and 1982). The toxic and hepatonecrotic action of CCI4 appears to be due to the production 
of an active metabolite by microsomal enzymes (Slater, 1966, 1972; McLean and McLean, 
1965). From the above studies, it has been widely accepted that CCI4 hepatotoxicity depends 
on the reductive dehalogenation of CCI4 catalysed by cytochrome P450 in the liver cell 
endoplasmic reticulum. Metabolism of CCI4 yields a variety of free radicals and electrophiles 
including: CCI3 (Poyer et al., 1980), iCClz (Wolf et al., 1977; Ahr et al., 1980), phosgene 
which arises from secondary action involving O2  (Shah et al., 1979; Kubic and Anders, 
1980, Pohl et al., 1980; 1981) and an electrophilic form of chlorine (Mico et al., 1982). 
Covalent binding of these reactive metabolites to cell constituents and the initiation of lipid 
peroxidation by some of them are considered to be the basic mechanism of CCI4 injury 
(Recknagel et al., 1977). Recknagel et al. (1989) recently reviewed the mechanisms of CCI4 
toxicity and included the recent development of secondary mechanisms in which raised Ca^^ 
concentration in the cytosol lead to cell degeneration.
In contrast to the analogous compound CCI4, there is no evidence that trichlorofluoromethane 
(CCI3F) is hepatotoxic (Clayton, 1966; Scholz, 1962; Jenkins et al., 1970). W olf et al. 
(1978) found that the microsomal fraction of the livers of several species is capable of 
converting CCI3F to CHCI2F under anaerobic conditions, analogous to the reported 
production of CHCI3 from CCI4 (Reiner et al., 1972; Uehleke et al., 1973). These authors
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concluded that under anaerobic conditions, CCI3F is not biologically inert and reacts in many 
respects like CCI4.
Dichlorodifluoromethane (CCI2F2), chlorotrifluoromethane (CCIF3) and carbon tetrafluoride 
(CF4) are of a lower order of toxicity compared to CCI4 and are thought to be biologically 
inert. There is little evidence for aerobic (Cox et al. , 1972 a, 1976) or anaerobic metabolism 
of these compounds.
The present investigation was carried out in order to find out whether CCI2F2, CCIF3 and CF4 
interacted with cytochrome P450 under either aerobic or anaerobic reducing conditions in a 
similar fashion to CCI4 and CCI3F, and to relate the structural differences arising from 
substitution of a fluorine by chlorine in the CC^-molecule to physico-chemical properties, 
uptake and metabolism of these compounds both in vitro and in vivo.
6.2 M ATERIALS AND METHODS
Inhalation exposures were conducted in a closed recirculating atmosphere exposure system 
which was described in Chapter 2, Section 2.3.
M ATERIALS
Rats and other materials used were described in Chapter 2.
CCI4 was obtained from British Drug House Ltd. (BDH) (Poole, Dorset, U .K .). CCI3F, 
CCI2F2 and CCIF3 were purchased from Fluorchem Ltd., Old Glossop, Derbyshire, U.K. and
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were used for the in vivo studies. CF4  was obtained from Aldrich Chemical Company Inc., 
P.O. Box 355, Milwaukee WI 5320 U .S.A ., and used only in the in vitro studies. CCI2 F 2 , 
CCIF3 and CF4 are gases at room temperature and therefore, were sampled by filling gas 
sample bags (SKC, Inc, PA 15330, U .S.A .), and the required aliquots were removed using 
a gas tight syringe. Details of the concentrations, and the rats used are given in Table 6.1.
The methods used for spectral binding studies, and biochemical and histological investigations 
were described in Chapter 2.
6.3 RESULTS
Table 6.2 shows the amol, AE and calculated log P values for the tetrahalomethanes. The 
calculated log P and amol values increased with increasing chlorine content. CCI4 has the 
highest log P and amol values while CF4  has the lowest values of the series. AE value for 
the series varied inversely with increasing chlorine content. In contrast to CCI4, CF4 has the 
highest AE value.
The uptake curve with CCI4 was characterized by an initial rapid phase which takes about 
25-40 min followed by an essentially first order phase (Figure 6.1). The magnitude of the 
initial uptake phase declined with increasing fluorine content (CCIF3 has the lowest value).
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Table 6.2 PHYSICO-CHEMICAL PROPERTIES OF
TETRAHALOMETHANES
Compound amol (Â^) AE (eV)
Log P 
(calculated)
CCI4 5 .6 9 1 4 .3 2 .8 7 5
CCI3 F 4 .8 5 1 4 .4 2 .4 3 5
C C L F . 3 .9 2 1 4 .9 1 .9 9 5
C C IF 3 3 .2 1 1 6 .9 1 .5 5 5
C F 4 2 .6 2 2 4 .7 1 .1 1 5
AE =  E(H O M O ) - E(LEM O )
H O M O  =  highest occupied  m olecular ornital
LE M O  =  low est em pty m olecular orbital
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Analysis of the first-order phase for CCI4 showed no evidence of saturated metabolic 
component (G. Loizou, personal communication). Similarly, CCI3F showed a first order 
metabolic uptake rate. Comparing CCI4 and CCI3F after a 3 hour exposure of rats by 
inhalation, the amount remaining in the animal was greater with CCI4 after each initial 
concentration (Figure 6.2). Moreover, this amount was concentration-dependent except at 
50ppm where a decrease in the amount retained by the animal was recorded. With CCI3F, 
the amount remaining in the animal was highest at an initial concentration of 20ppm and 
decreased with increasing atmospheric concentrations. There was no evidence for the uptake 
of CCI2F2 and CCIF3 (Figure 6.1).
The binding spectra of the five tetrahalomethanes with microsomal preparations from 
phenobarbitone-pretreated rats were all of type I binding class, exhibiting peaks at 385- 
388nm and troughs at about 420nm. The binding spectra and AA^ a^x values are given in 
Table 6.3.
The spectral binding constant (KJ was lowest with CCI4 which suggests that the binding 
affinity for hepatic P450 was greatest with CCI4. The values which increased with 
increasing fluorine content varied inversely with log P and amol.
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Figure 6.1 The Uptake Curves of Tetrahalomethanes
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Figure 6.2 Relationship Between the Amount of CCl^ and CCI3 F 
Retained in the Animal and the Initial Atmospheric Concentrations
Each value represents the mean of 4 rats ±S.E.M.
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Table 6.3 CONSTANTS DERIVED FROM THE BINDING SPECTRA OF
TETRAHALOMETHANES
Chemical K, (mM) A A ^ a x
CCI4 0 . 3 8 ± 0 .0 1 0 .1 4
CCI3 F 1 .6 0 + 0 .0 4 0 .1 3
CC I2F 2 1 .8 0  +  0 . 0 2 0 .0 3
C C IF 3 6 . 0 0 + 0 . 1 0 . 1 0
C F 4 2 0 .0 0  +  1 .9 0 .2 5
E ach value is the m ean o f  three determ inations +  S .E .M .
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Considering the first three compounds in the group (CCI4, CCI3F, CCI2F2) only, 
decreased with increasing fluorine content.
There was a correlation between the calculated log P and log K, values
(r =  0.96) in all the five tetrahalomethanes studied (Figure 6.3).
On reduction of the hepatic microsomal suspension of rats treated with phenobarbitone with 
sodium dithionite and addition of CCI4, the type I difference spectrum was abolished and a 
small peak at 420nm was recorded after about 40 seconds. The peak at 420nm disappeared 
and a peak at about 456nm started to appear after 1 minute reaching its maximum after 5 
min. CCI3F was found to interact with microsomes in a very similar fashion, giving peaks 
at 420nm and 451nm. The magnitude of the spectrum was less than that caused by CCI4.
The formation of reduced spectra of CCI4 and CCI3F in rat microsomal suspension was time- 
dependent. With CCI3F, the time required to achieve maximal spectral interaction was found 
to be about 20-25 min (Figure 6.4).
CCI2F2 and CCIF3 also yielded reduced spectra in chemically reduced microsomal 
preparations. The peaks were smaller than those produced by CCI4 or CCI3F with its 
maxima at 445nm and was formed within 5-8min. CF4  formed a very small reduced spectra 
at 445nm. No difference was found in the rate of formation of these spectra with time.
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Figure 6.4 Rate of Formation of the Spectral Peak with Carbon Tetrachloride 
and Trichlorofluoromethane and Sodium Dithionite-Reduced Microsomal Fraction
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Table 6.4 gives the wavelength of the maxima of the spectra obtained with the 
tetrahalomethanes and sodium dithionite-reduced microsomal preparations. At the end of the 
experiments, when CO was bubbled in the test cuvette, the magnitude of cytochrome P450- 
CO peak was found to reduce by 20% with CCI4 and CCI3F but not with the other 
compounds of the group.
Upon reduction of the microsomal preparations of rats pretreated with phenobarbitone with 
NADPH under anaerobic conditions and addition of either CCI4 (ImM) or CCI3F (ImM), 
reduced spectra was recorded with maxima at 452 and 450nm respectively. Figure 6.5 
shows the rate of formation of reduced spectrum of CCI3F in rat microsomes under 
anaerobic, NADPH-reducing conditions. The formation of the spectrum continued to 
increase and had not reached a maximum after 40 min of incubation.
CCI2 F 2 , CCIF3 and CF4 yielded reduced spectra in NADPH-reduced microsomes under 
anaerobic conditions with maximal interactions at about 416nm and were formed within 4 
min.
Table 6.5 shows the maxima of the NADPH reduced spectra with tetrahalomethanes and the 
microsomal preparations under anaerobic incubations.
After incubation of either CCI4 or CCI3F with sodium dithionite-reduced microsomal 
suspensions from phenobarbitone-treated rats, the typical difference spectra previously 
observed, was obtained.
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Table 6.4 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS OF 
TETRAHALOMETHANES WITH SODIUM DITHIONITE-REDUCED 
RAT MICROSOMAL FRACTIONS
Compound Final Concentration 
(mM)
Spectral Maxima 
(nm)
C C I 4 1 4 2 1 *  and 4 5 6
C C I 3 F 1 4 2 0 *  and 4 5 1
C C I 2 F 2 2 4 4 5
C C I F 3 2 4 4 5
C F 4 2 4 4 4  +
* sm all
+  very  sm all peak
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Figure 6 i  Rate of Formation of the Spectral Peak with Trichlorofluoromethane 
and NADPH- Reduced Microsomal Fraction under Anaerobic Conditions
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Table 6.5 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS OF 
TETRAHALOMETHANES WITH NADPH-REDUCED RAT 
MICROSOMAL FRACTIONS UNDER ANAEROBIC  
CONDITIONS
Compound Final Concentration 
(mM)
Spectral Maxima 
(nm)
C C I 4 1 452
C C I 3 F 1 450
C C I 2 F 2 2 415
C C I F 3 2 416
C F 4 2 416
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On the addition of Hb to reference and test cuvettes, the maximum spectral interaction 
(AAmax) shifted to 467nm with CCI4 and 460nm with CCI3F and a typical haemoglobin-CO 
difference spectra was obtained at 418nm. In incubations with CCI2F2 and CCIF3 with 
microsomes, similar difference spectra were formed but without a shift in the maxima at 
445nm. However, an Hb-CO peak at 418nm was formed which was much smaller. With 
CF4, no Hb-CO spectrum was observed which indicates absence of formation of CO. Similar 
results were obtained in incubations of CCI4 and CCI3F when NADPH was substituted for 
sodium dithionite under anaerobic conditions. With CCI2F2, CCIF3 and CF4, NADPH-Hb 
experiments were not done because these compounds exhibited peaks at about 418nm with 
NADPH-reduced microsomes.
Table 6 . 6  shows the wavelength maxima of the spectral interactions of tetrahalomethanes 
with microsomal preparations reduced with either sodium dithionite or NADPH under 
anaerobic conditions and in the presence of haemoglobin.
TISSUE GLUTATHIONE
There were neither changes in total glutathione of lungs nor in GSSG concentration of liver 
and lungs of any of the rats exposed to different concentrations of tetrahalomethane (data not 
shown). There was no significant decrease in hepatic total glutathione of rats exposed by 
inhalation to concentrations below 50ppm of CCI4. Rats exposed to 50ppm of CCI4 showed 
a significant decrease in hepatic total glutathione (P <  0.02) compared to control rats.
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Table 6.6 WAVELENGTH MAXIMA OF SPECTRAL INTERACTIONS OF 
TETRAHALOMETHANES WITH REDUCED MICROSOMES 
EITHER WITH SODIUM DITHIONITE OR NADPH UNDER 
ANAEROBIC CONDITIONS AND HAEMOGLOBIN
Compound Dithionite +  Hb (nm) NADPH +  Hb (nm)
CCI4  (ImM) 418 and 467 418 and 467
CCI3 F (2mM) 418 and 460 418 and 460
CCfF. (2mM) 418 and 445 nd
CCIF3  (2mM) 418 and 445 nd
CF4  (2mM) 444 nd
nd not done because these com pounds exhibited peaks at 418nm  w hen added to N A D P H -red uced  
m icrosom es from phenobarbitone-treated rats
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No significant effect was observed in liver total glutathione of rats exposed to CCI3F, CCI2F2 
and CCIF3 by inhalation (Table 6.7).
DETECTION OF REACTIVE INTERMEDIATES
Incubation of liver microsomes from rats pretreated with phenobarbitone with either CCI4 or 
CCI3F (concentrations 0.5 and 1 mM) reduced GSH and NADPH generating system in the 
presence of oxygen produced no GSH depletion and the values were similar to control 
experiments run simultaneously at same conditions in the absence of substrate. When the 
final concentrations of either CCI4 or CCI3F was increased to lOmM, there was a depletion 
of GSH (10 and 14 nmol/mg protein/30 min respectively). On the other hand, incubations 
of CCI2F2, CCIF3 and CF4 with microsomes and NADPH generating system, produced no 
alterations to GSH values. Table 6 . 8  shows the depletion in reduced GSH in microsomes 
from rats induced with phenobarbitone when incubated with tetrahalomethanes in the 
presence of oxygen.
When either CCI4 or CCI3F (lOmM) were incubated under anaerobic conditions with liver 
microsomes from phenobarbitone-treated rats, NADPH generating system and GSH, 
appreciable depletion of GSH was apparent (Table 6.9), the magnitude of which was greater 
than those observed under aerobic conditions. Approximately a 4-fold increase in GSH 
depletion was recorded with CCI4 while CCI3F showed more than 2.5-fold increase, in 
comparison with the respective aerobic incubations.
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Table 6.8 GSH DEPLETION IN RAT LIVER MICROSOMES UNDER
AEROBIC INCUBATION WITH TETRAHALOMETHANES
Compound Concentration
(mM)
GSH depletion* 
(nm ol/m g protein/30min)
e c u 10 10+0.5
CCI3F 10 14+1.1
CCI2F2 3 0
CCIF3 3 0
CF, 3 0
R esults represent the values o f  6  incubations +  S .E .M .
* R esults w ere corrected for the depletion  o f  G SH  that occurred in the control incubation w hich  w as
less than 13% (range 9-15% , n =  6 )
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Table 6.9 GSH DEPLETION IN RAT LIVER MICROSOMES UNDER
ANAEROBIC INCUBATION WITH TETRAHALOMETHANES
Compound Concentration
(mM)
GSH depletion* 
(nm ol/m g protein/30min)
control - 0*
CCI, 1 0 43 + 1.2
CCI3 F 1 0 38+ 0 .15
CC1 2F 2 3 7 + 0 .3
CCIF3 3 7 + 0.5
CF, 3 0
Each value represents the mean of 6  incubations ±  S.E.M. 
control - incubation in the absence of substrate.
No loss of GSH occurred in the control incubations
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Incubations with either CCI2 F 2  or CCIF3 (3mM) led to low levels of GSH depletion 
(7nmol/mg protein/30min) with the exception of CF4  where no GSH depletion were recorded 
(Table 6.9).
No GSH depletion was observed in either aerobic or anaerobic incubations of 
tetrahalomethanes with microsomal fractions when cofactors were omitted.
H IS T O L O G Y  AN D S E R U M  E N Z Y M E  A C T IV IT IE S
There was no rise in the activities of SDH, GDH or LDH in sera of rats exposed to different 
concentrations of tetrahalomethanes and values were similar to those obtained for control 
rats. No histopathological changes were noted in liver, lungs or kidneys obtained from rats 
exposed by inhalation to different concentrations of tetrahalomethanes which could be related 
to the compounds (data not shown).
6.4 D IS C U S S IO N
The effects of inhaled tetrahalomethanes in the rat have been investigated. The uptake curves 
for CCI4 show that it has an affinity towards metabolism (G. Loizou, personal 
communication). However, only a first order rate of uptake was obtained upon analysis of 
the uptake data which could be attributed to the low concentrations of CCI4 used in the 
experiment such that saturation of metabolism was not achieved. Higher concentrations 
should be employed in order to reach the saturable component for metabolism of this
177
compound. In comparison with its fluorinated analogues, a greater amount of CCI4 remained 
in the animal after 3 hour exposure by inhalation (Figure 6.2), possibly reflecting the 
dependence of uptake on lipophilicity. The fat, liver and lungs have been reported to have 
the highest concentration of CCI4 following exposure by inhalation (Paustenbach et al. , 
1986).
The decrease in the amount of CCI4  remaining in the animal at a concentration of 50ppm, 
or with CCI3 F at a concentration of above 20ppm (Figure 6.2), may suggest that the rate- 
limiting factor could be respiration rate as discussed previously with CHCI2 F (Chapter 5). 
Similar to CHCljF, the respiration rate may decrease rapidly due to an anaesthetic effect at 
high concentrations of CCI4  and CCI3 F with consequent decrease in the uptake of the vapours 
at these concentrations.
It is clear from the results that all trihalomethanes can interact with cytochrome P450 giving 
a type I binding spectra. The affinity of binding depends on the lipophilicity of the 
compound as measured by c log P value (Figure 6.3). The results show a greater interaction 
with CCI4  than with CCI3 F or other fluorinated analogues which was in contrast with Cox 
et al. (1976) who found greater interaction with CCI3 F. This finding was supported by the 
fact that CCI4  has the highest affinity for cytochrome P450 as well as the highest lipid 
solubility as reflected by log P. Uehleke et al. (1973) reported greater interaction with CCI4  
than with CCI3 F with phenobarbitone-pretreated rabbits which was in agreement with our 
findings. The binding site was proved by Cox et al. (1976) to be associated with 
phospholipid, as the type I spectrum was abolished after iso-octane extraction of the 
microsomal fraction. The linear relationship between log K, and either calculated log P or 
amol reflects a structure-activity relationship for this group of compounds.
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In in vivo experiments, both CCI4  and CCI3 F produced a decrease in total liver glutathione 
at the concentrations used but, only at high concentration (50ppm) significant depletion of 
total GSH was observed with CCI4 . These findings were in agreement with Pohl et al. 
(1981) who reported a decrease in hepatic total glutathione levels one hour after 
intraperitoneal administration of CCI4  to phenobarbitone-pretreated rats compared to controls. 
The in vivo results were supported by the depletion of reduced glutathione by CCI4  and 
CCI3 F in in vitro experiments upon incubation aerobically with reduced GSH, NADPH 
generating system and microsomes from rats pretreated with phenobarbitone. The magnitude 
of GSH depletion under aerobic conditions was lower with CCI4  and CCI3 F than with CHCI3  
(Chapter 5) which suggests that these two compounds can undergo metabolism with the 
possible formation of phosgene (COCI2 ) which reacts with glutathione to produce GSCOSG. 
The most likely source of COCI2  is a reaction of the trichloromethyl radical (formed 
reductively, see later Figure 6 .6 ) with molecular oxygen as illustrated below:
CCI3 +  O2  > 0 -0 -CCI3  > [H0 -0 -CCI3]
ÔH + cr
COCl,
Such a scheme has been proposed by Pohl and Mico (1984). Earlier work by Pohl et al. 
(1981) identified GSCOSG upon incubation of CCI4, reduced GSH, NADPH generating 
system and liver microsomes from rats treated with phenobarbitone.
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In the present study, the minor evidence for uptake of CCI2F2 and CCIF3 was consistent with 
absence of glutathione depletion either in in vivo or in vitro experiments. These findings 
suggest that formation of phosgene, or COCIF, and the related GSCOSG, does not occur in 
vivo or in in vitro experiments with these compounds under aerobic conditions.
Upon reduction of liver microsomes from rats treated with phenobarbitone either with sodium 
dithionite or enzymatically under anaerobic conditions with NADPH, CCI4 and CCI3F gave 
reduced spectra with peaks at about 450nm. These results confirm previous findings on the 
binding of CCI3F, CCI4 and other haloalkanes to cytochrome P450 both under aerobic and 
anaerobic conditions (Cox et al., 1976). Uehleke et al. (1973) found that the formation of 
the reduced spectrum by NADPH-reduced microsomal preparations under anaerobic 
conditions with CCI4 parallelled the formation of CHCI3. Moreover, CHCI2F has been 
identified as a metabolite of anaerobic dechlorination of CCI3F by rat liver preparations in 
vitro (Wolf et al., 1978).
CCI2F2 and CCIF3 gave similar difference spectra to CCI4 and CCI3F with sodium dithionite- 
reduced microsomes, however, the magnitude of the peaks were smaller. Such ligands 
appear to be formed by a reductive process which may suggest that CCI2F2 and CCIF3 could 
follow the same scheme suggested by W olf et al. (1977) for the reductive metabolism of 
CCI4 and CCI3F.
Inclusion of haemoglobin in incubations containing either CCI4 or CCI3F and reduced 
microsomes from rats treated with phenobarbitone led to the formation of the haemoglobin- 
carbon monoxide (Hb-CO) spectrum at 418nm. These results were in agreement with W olf
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et al. (1977, 1978), who suggested that these compounds underwent reductive dechlorination 
which led to the formation of a carbene. Complexes with ferrous cytochrome P450 and the 
formation of Hb-CO were also observed with CCI2 F 2  and CCIF3  but to a lesser extent. 
Formation of a carbene similar to that formed with CCI4 and CCI3 F may provide a feasible 
explanation (Figure 6 .6 ). At low concentration of oxygen the haloalkane can compete 
effectively for the electrons of cytochrome P450 (Nastainczyk et al., 1977).
CCI4 and CCI3F at a concentration of lOmM, under anaerobic conditions, depleted GSH 
when incubated with microsomes from phenobarbitone-pretreated rats, NADPH generating 
system and reduced GSH. The depletion was greater when the incubation was carried out 
under anaerobic conditions compared to aerobic incubations. Such depletion was dependent 
on microsomal mono-oxygenase metabolism as indicated by omission of cofactors. CCI2 F 2  
and CCIF3 produced a weaker response compared to CCI4 and CCI3F when incubated 
anaerobically with this reduced system. These findings could be due to either the higher 
vapour pressures of these compounds or to their lower affinity for cytochrome P450, or both. 
Similar findings were obtained by Garle and Fry (1989) who related the weak GSH depletion 
observed with trichloroethylene to the high volatility of this compound.
The higher magnitude of GSH depletion with CCI4 and CFCI3, and to a lower extent with 
CCI2F2 and CCIF3 under anaerobic conditions, is evidence for the reductive metabolism of 
this series of compounds and the formation of reactive intermediates, possibly a radical or 
a carbene or both. Figure 6 . 6  shows a speculative reductive metabolic pathway for 
tetrahalogenomethanes.
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F e 3 + e ' F e ^ + F e ^ + e F e ^ +
c x . C X , [ c x , r ? [cx ,]-
B D
F e : + F e ^ + 2e - F e ^ +
: C X g C X 3 C X 3
Figure 6.6 Possible Metabolic Scheme for the Metabolism of 
T e t r a h a l o m e t h a n e s  u n d e r  A n a e r o b i c  R e d u c i n g  
Conditions
and Fe^  ^ represent the oxidised and reduced forms of P450 respectively 
A represents complex giving type I spectrum 
B represents complex giving reduced spectrum with NADPH  
D represents complex giving reduced spectrum with sodium dithionite
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The formation of the 467nm and 460nm peaks with CCI4 and CCI3F respectively and 445nm 
peak with CCI2F2 and CCIF3 could be due to the interaction of the reactive metabolite :CX2 
with reduced microsomes and formation of complex F (rCX-Fe^"^). Complex B and D could 
account for the formation of the reduced spectra at 415-416nm and 450-452nm with NADPH- 
and sodium dithionite- reduced microsomes respectively with the tetrahalogenomethanes.
The free radical complex E ( CX3 -Fe^^) which may be formed by dehalogenation of the 
transient intermediate complex C could explain the destruction of P450 observed with CCI4 
and CCI3F. Similar to the trihalomethanes (Chapter 5), carbenes can interact with 
nucleophiles as follows:
H R /X
:CXn +  H 2 O  > / C   > 2 H X  +  C O
H  ^
Gs
:C X 2  +  G S H   *
H  X
The hydrolysis of the carbene could explain the formation of CO with tetrahalogenomethanes 
(CCI4, CCI3F, CCI2F2 and CCIF3) and sodium dithionite-reduced microsomes. The reaction 
of the carbenes with glutathione could account for the depletion of reduced glutathione 
observed with these compounds anaerobically.
Unlike CHF3  (Chapter 5), CCIF3  may be reductively metabolized to carbene :Cp 2  which 
required cleavage o f the strong C-F bond. For some reason or another, partial cleavage of 
this bond may occur under anaerobic conditions with this compound, with a consequent low
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production of carbene :Cp 2  which upon hydrolysis may account for the lower CO formation 
and limited reduced GSH depletion.
Absence of any histopathological changes, coupled with the lack of release of tissue enzymes 
into sera of rats exposed by inhalation to tetrahalogenomethanes was not surprising. The low 
exposure concentrations of CCI4 used, could be a reasonable explanation for the results 
obtained. Accumulation of lipid and necrosis of centrilobular hepatocytes due to CCI4 is 
directly related to the dose of chemical administered (Chopra et al., 1972; Das et al., 1974). 
Moreover, augmentation of drug microsomal enzymes including cytochrome P450 by 
phenobarbitone considerably increases the subsequent toxic manifestation of CCI4 in animals 
(Nayak et al., 1975; Garner and McLean, 1969). The results with CCI3F confirmed other 
reports on the absence of hepatotoxic effects with this compound (Clayton, 1966; Scholz, 
1962 and Jenkins et al., 1970). Similar findings were obtained with CCI2 F 2  which was in 
agreement with Prendergast et al. (1967) who studied the effect on experimental animals of 
long-term inhalation of some halogenated alkanes including CCI2 F 2 .
In conclusion, CCI2F2 and CCIF3 may react in many respects as CCI4 and CCI3F especially 
under anaerobic conditions and their metabolic activities could be related to the physico­
chemical properties of the series. CF4  seems to be metabolically inert.
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CHAPTER?
GENERAL DISCUSSION
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Although the correlations shown in Figures 3.4 and 4.4 were with calculated logP values, they 
are in very good agreement with expenmentally determined values for Upidiaqueous partition 
reported in the literature ( Table 7 . 2  ).
but in particular the bloodiair partition is likely to be of major importance in determining the rate 
of uptake of these compounds. As very few of these parameters have been experimentally 
determined for the compounds studied, it was not possible to investigate possible correlations.
The uptake and metabolic effects of some inhaled structurally related halogenoalkanes have 
been investigated in vivo, and the potential of these compounds to be metabolized by the liver 
have been studied in vitro.
The solubilities of chemicals in blood and the partition coefficient between blood and various
tissues are important parameters that determine the extent of uptake and tissue loading in
(see Figures 3.4 and^.4). 
animals during an inhalation exposuret They help characterise the internal tissue exposure
as it is related to inhaled concentration.
The results presented in this thesis indicate that the rate of uptake of haloalkanes decreased 
with increasing fluorine contents for the classes of compounds studied, CH3CX3, CH2X2, 
CHX3 and CX4, where X =  Cl or F . Since the uptake curves of these compounds are 
attributed to distributional phenomena involving uptake from the lung, delivery to the liver 
via the blood stream and hepatic metabolism, it is likely that more than one physico-chemical 
characteristic is involved. However, log P is likely to be a major factor in view of the
-f-
lipophilic nature of these series of compounds^
7.1 BINDING TO CYTOCHROM E P450
The binding of all four classes of halogenoalkanes with oxidised cytochrome P450 in 
microsomal preparations, which are all of the type I form, indicates that there is a potential 
for metabolism. However, spectral interactions is not a pre-requisite for metabolism, as 
phospholipase C digestion abolishes type I spectra, but does not prevent metabolism of type 
I substrates (Chaplin and Mannering, 1970). The interaction of halogenoalkanes with
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oxidised cytochrome P450 is predominantly with the phospholipid component. Evidence for 
the dependence of the type I spectra on the presence of phospholipid were given by 
treatments with iso-octane (Liebman and Estabrook, 1971) or phospholipase C (Chaplin and 
Mannering, 1970) or phospholipases C and D (Elling and Di Augustine, 1971) which 
destroys the type I spectral interaction. In the present experiments, evidence for the lipid 
nature of type I binding site is given by the value of spectral constant (KJ for various 
haloalkanes (Table 7.1).
Increasing substitution of chlorine for hydrogen in these compounds resulted in a decrease in 
the Kg values, i.e. a higher affinity for cytochrome P450. The substitution of fluorine for 
a chlorine results in an increase in K, values i.e. lower affinity except within the chloroform 
group. Similar findings were obtained by Cox et al. (1976) when they studied the binding 
of some haloalkanes to cytochrome P450. In this present study also, significant correlation 
(r =  0.75, P <  0.02) was established between lipophilicity as indicated by c log P and 
logarithmic values of the binding constants of all compounds under investigation in this thesis 
(Figure 7.2).
From the above, it can be concluded that in general the more lipophilic the halogenoalkane 
is, the greater the affinity of binding to cytochrome P450.
The lipophilicity of the various halogenoalkanes studied is given by the calculated log P 
values (Table 7.2). Increasing substitution of chlorine for hydrogen in these compounds 
results in an increase in the calculated log P value representing the increase in the lipophilic
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Table 7.1 TH E BINDING AFFINITIES O F HALOALKANES FOR
M ICROSOM AL CYTOCHROM E P450
Compound Kg (mM)
C H 2 C I 2 6 . 0 0
C H C I 3 2 .2 7
C C I 4 0 .3 8
C C I 4 0 .3 8
C C I 3 F 1 .6 0
C C I 2 F 2 1 .8 0
C C I F 3 6 . 0 0
C F 4 2 0 . 0 0
C H C I 3 2 .2 7
C H C ^ F 1 2 . 0 0
C H C I F 2 3 .5 7
C H F 3 0 .6 7
C H 2 C I 2 6 . 0 0
C H 2 C I F 2 ^ 0
C H 2 F 2 1 1 . 1
C H 3 C C I 3 0 .6 0
C H 3 C C I 2 F 1 .0 3
C H 3 C I F 2 9 .1
C H 3 C F 3 (w ea k  in teraction )
F igures have been  presented for each group o f  com pounds in previous Chapters
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Figure 7.1 Relationship between Log P and Molar Polarizability of Halogenoalkanes
l .c a ^ 2- CCl^ 3- c a ^ 2 *^ S- CF  ^6-ŒCy7- CHCy' 8- CHCIF29- CHF3 
lO-CH^Cyi-CHÿlF 12-01^213. Cf^QgW.CH^CCy’ 15.CH^CIf^l6. CHjCFg
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Table 7.2 CALCULATED LOG P VALUES OF HALOALKANES
Compound ! Log P(measured)* Calculated log P
CH3 CI 0.91 0.936
CH2 CI2 1.25 I 1.249
CHCI3 1.97
'
1.952
CCI4 2jG  : 2.875
CCI4 2jG 2.875
CCI3 F 2.53 2.435
CCI2 F2 2.16 1.995
CCIF3 1.65 1.555
CF4 1 1.18 1.115
CHCI3 , 1.97 1.952
CHCI2F j i.55 1.512
CHCIF2 1.08 1.072
CHF3 : 0.64 0.632
CH2 CI2 1 1.25 1.249
CH2 FCI 0.86 . 0.809
CH2F 2 : 0.56 0.369
CH3 CI 0.91 0.936
CH3 F [ 0.51 i 0.496
CH3 CCI3 ; 2.49 2.481
CH3 CCI2F N.D. : 2.041
CH3 CCI2 F 1 N.D. 1.601
CH3 CF3 I N.D. , 1.161
N .D . not determined
P is defined as the oil: air partition coefficient
* These are experimental values obtained from the literature and supplied by 
Dr. B .C .Jones (personal com m unications )
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character of the compound. Substitution of chlorine by fluorine decreases the lipophilicity 
of the compound below that of the chlorine analogue. Molar polarizability (amol) makes an 
important contribution to the partition between two phases, and therefore is a major 
component of the hydrophobic parameter log P (Lewis, 1981). Since a positive correlation 
(r =  0.7, P <  0.01) was established between calculated log P and am ol for all compounds 
investigated in this study (Figure 7.1), all findings which are directly related to log P may 
be related to am ol as well.
7.2 ANAEROBIC REDUCTION O F HALOALKANES
Upon reduction of microsomal preparations from rats treated with phenobarbitone either with 
sodium dithionite or NADPH under anaerobic conditions, various halogenoalkanes produced 
different behaviour. The chlorinated halogenoalkanes produced difference spectra with Soret 
bands between 450 and 465nm, whereas their fluorinated analogues gave difference spectra 
between 440 and 450nm and only with sodium dithionite as a reducing agent. It is likely that 
the Soret bands represent low spin ligand complexes of reduced cytochrome P450. Such 
ligand complexes appear to be formed as a result of a reductive process upon the 
corresponding halogenoalkanes. Similar findings were reported by W olf et al. (1977) on the 
study of the reduction of polyhalogenated methanes by liver microsomal cytochrome P450. 
In contrast to the present study, these authors found no difference spectra with 
dihalomethanes or monohalogenated methanes. Such spectral shifts have been observed for 
several halogenomethanes including: CCI4 (Wolf et al., 1977; Ullrich and Schnable, 1973),
191
2
R = 0 .7 3  P <  0 .0 2
1
0
-1
1 2 30
Calculated logP
Figure 1 2  Relationship Between Calculated LogP and Log Ks Values of Halogenoalkanes
1- CH2CI22- CHgClF 3- CH2F24. CHCI35- CHCIgF 6- CHClFgT- CH% 8- CCI4 
9-CCI3F IO.CCI2F2II-CCIF3 12- CF4I3.CH3CCI3I4-CH3CCI2F 15- C Ï Ç 1F2
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CFCI3 (Wolf g/ a l ,  1977; Cox et a l ,  1976; Wolf g; a l ,  1975), CHBrg (Anders et a l ,  1977), 
CHI3 and CHCI3 (Wolf et al., 1977). Similar spectral interactions have been observed with 
other compounds including hydralyzines such as ‘Nardil’ (Netter and Seidel, 1964), fluorene 
and 2-nitropropane (Ullrich and Schnable, 1973), ethyl isocyanide and CO (Omura and Sato, 
1964 a). The formation of these reduced spectra was time-dependent for most of the 
chlorinated alkanes studied. This may be due to the slow formation of a complex with 
cytochrome P450. This result was in agreement with the findings of W olf et a l  (1977) who 
identified this complex by infrared spectroscopy. On the other hand, the reduced spectra 
formed with the fluorinated alkanes were not time-dependent except for CCI3F which showed 
similar characteristics to CCI4.
Formation of a carbene as the final step in the reductive metabolism of halogenoalkanes could 
explain the Soret band formation at wavelengths beyond 450nm. Evidence for the formation 
of carbene complexes, which accounts for the spectral interactions in this region have been 
reported by Mansuy et a l  (1974) and W olf et a l  (1977). Ullrich et a l  (1978), concluded 
that the haloalkanes can give rise to various intermediates produced by successive one 
electron reductions at cytochrome P450. The initial product is a carbon-centred radical 
which, depending upon its stability and chemical characteristics, may induce lipid 
peroxidation (when oxygen is present) or may be further reduced to yield another 
intermediate, the carbene, which can be subsequently hydrolysed to give CO. In the present 
experiments CO was trapped using haemoglobin as previously described by W olf et a l  
(1977).
193
The reductive metabolism of halogenoalkanes to a radical and a carbene can be incorporated 
into a scheme similar to that proposed by W olf et al. (1978) for the mechanism of the 
anaerobic metabolism of CCI3F by microsomal mixed function oxidase system, as shown in 
Figure 7.3. The mechanism proposes the existence of various intermediate complexes with 
cytochrome P450 which may include:
(A and B) halogenoalkane, giving either type I with oxidised P450 or reduced
spectra with sodium dithionite or NADPH reduced microsomes,
(C and D) free radical,
(E) carbanions,
(F) carbene.
According to the proposed scheme (Figure 7.3), the formation of radicals and carbenes is 
more likely to occur with the chlorinated compounds rather than their fluorinated analogues. 
This may be due to the difficulty in cleaving the strong C-F bonds as discussed previously 
in the results Chapters. Chemical evidence for such a reductive elimination of halogens by 
reduced cytochrome P450 was found to occur with halothane. Under reducing conditions, 
a complex was formed which could also be formed by addition of 1 , 1 , 1 -trifluorodiazoethane 
suggesting the corresponding carbene as a ligand (Mansuy et al., 1974).
In view of the results discussed above, it is evident that a close relationship exists between 
the formation of the postulated carbene and the release of CO. With some fluorinated 
alkanes, CO was not detected although Soret bands were formed in the region of 445nm. 
In those cases, formation of carbenes is unlikely due to the difficulty in cleaving the strong
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Figure 7.3 Postulated Mechanism of Reductive Metabolism of Halogenoalkanes
Fe^^ and Fe^"  ^ represent the o x id ise d  and reduced  fo rm s o f  P 4 5 0  r esp e ctiv e ly .  
A  represents co m p lex  g iv in g  type I spectrum  
B rep resents co m p lex  g iv in g  reduced  sp ectru m
195
C-F bond (as in the case of CH2 F 2 , Chapter 4) and the peaks observed at 445nm could be 
due to the formation of complexes of those compounds with reduced cytochrome P450. 
That no CO was formed in some other cases such as with CH 2 CI2  could be explained by 
hydrolysis of the carbene, :CH 2  to methanol and not to CO as described previously (Chapter 
4). Another explanation may be that the formation of CO was so low that it could not be 
detected by haemoglobin trapping as previously suggested in the case of CHCI3  with 
NADPH-reduced microsomes.
It was interesting to note that despite the formation of peaks at 445nm with chemically 
reduced (sodium dithionite) microsomes, some fluorinated alkanes gave peaks at 415-417nm 
with NADPH-reduced microsomes. These transient peaks could be attributed to the 
formation of complexes of the compound with NADPH-reduced microsomes.
7.3 DETECTION O F REACTIVE M ETABOLITES
Other evidence for the formation of reactive, electrophilic intermediates, including the 
carbon-centred radical or carbene complexes, by cytochrome P450 was provided by depletion 
of glutathione in in vitro incubations of haloalkanes with microsomes from phenobarbitone- 
treated rats, NADPH generating system and GSH. Only some of the chlorinated alkanes 
(CHCI3, CCI4), and exceptionally CCI3F, depleted GSH under aerobic conditions. Similar 
findings were reported by Garle and Fry, (1989) on the ability of 27 compounds to mediate 
depletion of GSH in fortified liver microsomal incubations via production of reactive 
metabolites. However, under anaerobic conditions, the magnitude of GSH depletion was 
increased with chlorinated alkanes suggesting that the reductive metabolism was more
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important in the generation of reactive electrophiles than the oxidative route. Such depletion 
was dependent on microsomal mono-oxygenase system as indicated by the omission of 
cofactors. On the other hand, most of the fluorinated alkanes showed GSH depletion under 
anaerobic conditions only. This suggests that these compounds may mainly undergo 
reductive metabolism with the formation of reactive intermediates which react with reduced 
glutathione under anaerobic conditions. This is of particular interest with regard to CHF3 
which resulted in GSH depletion in vivo. This suggests that CHF3 could be metabolised 
principally by a reductive mechanism in the whole animal.
On the basis of studies reported in this thesis, it is clear that the halogenoalkanes studied can 
give rise to various intermediates produced by reduction at cytochrome P450 under anaerobic 
conditions and possibly in less well oxygenated conditions which may pertain in vivo. Under 
these conditions, the haloalkanes can compete effectively for the electrons of cytochrome 
P450 (Nastainczyk gr 7^ /., 1977).
7.4 TISSUE TOTAL GSH
One of the most important biological roles of GSH is that of reaction with the electrophilic 
intermediates of metabolism of foreign compounds. The formation of water soluble GSH 
conjugates allows the detoxification of reactive intermediates and facilitates the excretion of 
toxic compounds.
In the current experiments some of the chlorinated alkanes were found to decrease tissue total 
GSH when rats were exposed by inhalation. Such depletion suggests the formation of
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reactive intermediates as there was no evidence for oxidation of GSH to GSSG i.e. there 
were no changes in GSSG concentration of liver of rats exposed by inhalation to 
halogenoalkanes. The depletion of GSH by these compounds may depend on the isoenzymes 
of cytochrome P450 responsible for metabolism. For example, phenobarbitone (Gamer and 
McLean, 1969 and Scholler, 1970), DDT (Gopinath and Ford, 1975; Mclean and Mclean, 
1966), 3- methylcholanthrene (Lavigne and Marchand, 1974) and polychlorinated biphenyls 
(Carlson, 1975) are known to induce hepatic MFO activity and to potentiate the hepatotoxic 
action of one or more haloalkanes in experimental animals.
In contrast, some of the fluorinated alkanes under investigation did not alter hepatic GSH. 
This effect may possibly be reflected in the dependence of uptake in lipophilicity or may be 
due to lack of formation of reactive intermediates with these compounds in vivo.
The experimental results also showed absence of GSH depletion in lungs of rats exposed to 
different concentrations of the halogenoalkanes studied. These results, coupled with absence 
of histological changes in lungs, provides evidence that the lung is not a major organ for 
metabolism of the compounds under investigation. As the liver is the primary organ involved 
in most xenobiotic metabolism and it is perfused with about 25% of the cardiac output, it is 
not surprising that biotransformation of most inhaled gases and vapours occurs in tissues 
remote from the lungs. Inhaled chemicals are transported from the lungs to the metabolizing 
organs by the systemic circulation.
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7.5 SERUM ENZYME ACTIVITIES
Serum enzyme increases are such sensitive indicators of tissue damage that they are often 
detected before other clinical or pathological changes are evident. Increase in the activity 
of several liver-specific enzymes in the serum have been detected in animals suffering from 
different types of hepatic damage. Brondeau et al. (1983) reported significant changes in the 
activity of serum SDH and GDH following low levels of short-term inhalation of industrial 
hepatotoxicants in rats, which were in corroboration of work by Clampitt, (1978). This 
author had previously reported that measurement of transaminase activities in plasma, 
conventionally used as liver function test, was unable to reveal minimal liver damage. SDH 
has been widely used to evaluate the hepatotoxicity of CCI4  (Korsrud et al., 1972; Jaeger et 
al., 1975 a; Van Stee et al., 1982; Dooley, 1984).
In the present study, only one of the compounds caused a rise in serum enzyme activities in 
rats after their exposure by inhalation. CHCljF was the exception in that its inhalation 
caused a significant rise in the activity of SDH but not GDH. Such responses may suggest 
that the damage occurs only to the cytoplasmic organelles but not to the mitochondria where 
GDH is more prominent. Lack of increases in serum enzyme activities, except for CHCI2F, 
was consistent with the absence of tissue damage observed on examination of tissues 
histologically.
The low atmospheric concentrations of some of the halogenoalkanes used, particularly in the 
case of CCI4  and CHCI3 , the absence of induction of microsomal enzymes in the in vivo 
experiments, and the low order of toxicity of some of the other compounds may be the
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reasons for no increase in serum enzyme activities and the absence of lesions in tissues in 
these studies.
7.6 CONCLUSIONS
1. The uptake and metabolism of the halogenoalkanes of the current investigation depend 
largely on their lipophilic properties, which increased with increasing chlorine content of the 
compound.
2. Since the uptake curves for some of the compounds are attributable to distributional 
phenomena and possibly more than one metabolic process, it is likely that more than one 
physico-chemical characteristic is involved in describing their biological behaviour.
3. The rank order of the biological properties investigated for some compounds parallels 
those of the physico-chemical properties, log P, and amol with linear relationships between 
them. No simple relationship was found between the biological properties and AE.
4. Under anaerobic conditions some of the fluorinated alkanes are not biologically inert and 
they can react in many respects like CCI4.
5. Some of the compounds studied may undergo reductive metabolism to carbon-centred 
radicals, carbenes or other reactive intermediates.
2 0 0
6 . Due to the low order of toxicity, uptake and metabolic activities, some of the fluorinated 
alkanes studied e.g. CH2F2, CF4, CH3CCIF2 and CH3CF3 might be useful replacements for 
chlorinated analogues in industry, however, most of these compounds are gases at room 
temperature.
The results reported in the previous chapters on in vitro metabolic effects of halogenoalkanes 
especially under anaerobic conditions, lead one to suggest that further studies should be 
undertaken to identify the reactive intermediates formed by these compounds. Also 
identification of metabolites formed in vivo is of equal importance for these compounds for 
which there is evidence of metabolism from the uptake experiments, and where there is 
evidence of changes in tissue glutathione. Further studies require the induction of 
microsomal enzymes with different inducers and the effect of this on uptake and toxicity of 
these compounds.
2 0 1
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